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Abstract 
Since most of human diseases are related to genetic mutations, during the past two decades, 
identification of such mutations has attracted much attention. Detection of these mutations is 
mainly based on hybridization with the complementary reporter probes.  
Nucleic acid detection takes place by changing either the reporter’s fluorescence intensity or 
the colour of its fluorescence. The use of fluorescent probes for nucleic acid detection has 
attracted much attention due to its efficiency, the ease of synthesis and availability of 
commercial reporters that facilitate the probe synthesis. Nowadays, most of nucleic acid 
detection using fluorescent probes relies on quenching of fluorescence by energy transfer 
from one fluorophore to another or to a nonfluorescent molecule (quencher). The most 
common, widely used, quencher in fluorescent probes is 4-(N,N-dimethylamino)azobenzene-
4'-carboxylic acid (DABCYL).  
The goal of this thesis was to introduce new quenchers which structurally mimic the 
universal quencher DABCYL into peptide nucleic acid (PNA), DNA and RNA probes. These 
quenchers are also characterized by their ability to undergo photoisomerization upon 
illumination with light.   
Chapter 2 describes the synthesis of a novel azobenzene-PNA quencher; incorporation of the 
PNA quencher into PNA-molecular beacon probe and demonstration of efficient quenching 
ability upon hybridization with the complementary DNA sequence.  
Chapter 3 describes the synthesis of a new modified azo-based uracil PNA monomer and 
evaluation of its quenching ability by incorporation of the PNA monomer in a dual peptide 
sequence that is amenable to enzymatic degradation. The modified azo-based uracil moiety 
has shown the ability to quench the fluorescein emission; upon enzymatic cleavage of the 
peptide, fluorescent signal was recovered. 
 Chapter 4, based on the proven quenching ability of the modified azo-based uracil, this 
modification was introduced into deoxyribo- and ribonucleosides. The photoisomerization 
and halochromic behavior has been investigated on the synthesized compounds. 
 iv 
 
The advantages of this nucleobase modification are: 1) introduction of novel quencher, 2) 
potential duplex stabilization by retaining the ability of formation of hydrogen bond between 
the modified nucleobase and the complementary nucleobase, 3) potential photoregulation 
ability of azo-based modified nucleobase containing oilgomers with responding to incident 
light. 
Chapter 5 describes the synthesis of modified acridine-based uracil PNA monomer and 
evaluation of its fluorescence property. 
Keywords 
Dimethylaminoazobenzene, peptide nucleic acid PNA, DNA, photochromic nucleosides, 
quencher, fluorescent probes and acridine 
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Chapter 1  
1 Azobenzene and Its Application in Nucleic Acid Chemistry 
1.1 Nucleic acid overview 
Since the discovery of the three dimensional structure of DNA double-helix in 1953 by 
Watson and Crick,
1
 nucleic acids have been recognized as key components of life. This 
discovery encouraged many scientists to devote effort to explore the emerging science of 
molecular biology. Without a doubt, all living organisms need to reproduce. To ensure 
the continuation of their species, genetic information must be transferred from                   
a generation to the next. This idea led scientists to question how these biological 
processes took place.  
In 1958, Francis Crick
2 
was the first to propose the concept of the central dogma of 
molecular biology. Simply, it describes the flow of information via biological processes 
involving transcription of DNA to RNA which is then translated to protein. Protein is 
never back-translated to RNA or DNA, DNA is never created from RNA except in case 
of retroviruses. Furthermore, DNA is never directly translated to protein.   
As shown in (Fig.1-1), the central dogma of molecular biology is represented in three 
stages: Firstly, replication of DNA which involves the copying of DNA. Secondly, 
transcription involves the formation of mRNA, a single stranded ribonucleic acid that 
carries the genetic code from the DNA in the nucleus to the sites of protein synthesis in 
the cytoplasm. Thirdly, translation of mRNA to proteins which are responsible to perform 
all of the body's essential functions as growth, repair, metabolizing food, fighting 
infections and much more.  
If a mutation occurs in a gene, this can lead to production of a completely distorted 
protein that is unable to carry out its function or it may change the amount of a protein 
being produced. To control the effect of mutations, unique strategies were established 
based on oligonuclotides (ONs) namely antigene and antisense. In the antigene strategy, 
nucleic acid analogues are designed to recognize and bind to the complementary 
2 
 
sequence in a particular gene (DNA) and thereby interfere with the transcription of that 
particular gene (thus inhibit the formation of mRNA). While in the antisense strategy the 
nucleic acid analogues are designed to recognize and hybridize to a complementary 
sequence in mRNA and thereby stop its translation to protein and therefore effectively 
turn that gene "off". 
 
Figure ‎1-1: The central dogma of molecular biology. Adapted from    
                      http://www.accessexcellence.org /RC/VL/GG/central.php. 
Oligonucleotides have also been shown to be of particular value as diagnostic agents that 
are easily labeled with reporter groups as fluorophores and bind with its complementary 
nucleic acids with high and specific affinities. 
Hybridization between nucleic acids to form DNA:DNA or DNA:RNA duplexes is 
ascribed to the specific binding between the nitrogenous nucleobases in each strand. It is 
known that guanine (G) pairs with cytosine (C) and thymine (T)/(uracil (U) in case of 
RNA) pairs with adenine (A) via the hydrogen bonding interactions shown in (Fig. 1-2). 
3 
 
 
Figure ‎1-2: Watson-Crick base pairing between A: T and G:C.  
A typical DNA duplex is formed by two strands that run in opposite directions to yield a 
helical structure (Fig. 1-3). These strands are composed of deoxynucleosides dA, dC, dG 
and dT which is connected together via negatively charged phosphate groups. The 
stability of the DNA duplex is determined by the composition of the DNA sequence and 
the ionic conditions of the aqueous environment.   
 
Figure ‎1-3: DNA duplex structure. 
1.2 Automated DNA synthesis 
Nucleic acids are naturally synthesized within the biological environment via 
bioreactions that are catalyzed by enzymes. However, there is a huge need for millions of 
DNA assays to be able to examine antigene and antisense probes. Currently, nucleic acids 
can be synthesized in laboratory with sequences similar to the naturally occurring DNA 
4 
 
strands. In addition, synthesis of DNA strands bearing chemically modified nucleobases 
that possess novel functions and unique properties is possible. This innovation leads to 
production of numerous DNA oligonucleotides with potential biological applications.  
Currently, a well established methodology called solid support synthesis of oligo- 
nucleotides3 is widely used for the synthesis of DNA sequences using an automated 
instrument, the DNA synthesizer. This technique is extremely useful because it 
provides a rapid and inexpensive access to custom-made oligonucleotides of the desired 
sequence. The phosphoramidite protocol is the most common strategy for DNA 
synthesis, this protocol is characterized by using nucleotide phosphoramidite units 
bearing different bases as illustrated in (Fig. 1-4). Each phosphoramidites is composed of 
nucleobase with suitable protecting group for the exocyclic amine, deoxyribo sugar with 
dimethoxytrityl (DMT) group protect the 5`-OH and phosphate with diisopropylamine 
and 2-cyanoethyl groups which are very essential to order the synthesis direction.  
 
Figure ‎1-4: Composition of commercial available phosphoramidite monomers. 
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Automated DNA synthesis is carried out by using controlled-pore glass (CPG) support, 
the phosporamidite with the different nucleobases are loaded into the commercially 
available DNA synthesizer and simply by choosing the desired DNA sequence through a 
program, the synthesis can be achieved in few hours based on the length of the DNA 
sequence. As illustrated in (Fig. 1-5), the DNA synthesis cycle consists of four stages 
namely detritylation, coupling, capping and oxidation. For every synthesis cycle, one 
nucleotide is added at a time for the growing oligonucleotide through the four steps until 
the desired sequence is built. In fact, the desired sequence may be accompanied with 
undesired oligonuclotide species in different length due to incomplete synthesis during 
the process. After synthesis completion, the oligonucleotide is released from the support 
under basic conditions, generally with ammonium hydroxide, is purified by reversed- 
phase high pressure liquid chromatography (RP-HPLC) to afford the desired sequence. 
The pathway to release the oligonucleotide from the solid support is shown in (Fig. 1-6). 
 
Figure ‎1-5: Traditional solid-phase phosphoramidite oligonucleotide synthesis cycle. 
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Figure ‎1-6: Release of the oligomer from the universal support by NH4OH. 
Although the utility of the phosphoramidite methodology for oligonucleotide synthesis 
for several biological uses is satisfactory, its usage for production of large-scale 
oligonucleotide synthesis was accompanied with side-reactions, which were tolerated in 
small-scale synthesis. These side reactions are depurination of protected bases due to 
repetitive acid treatment at detritylation step, and missing one or more of the correct 
nucleotides in the desired sequence by the effect of acid treatment leading to formation of 
sequences with mutations; thusly, the presence of such mutations limits its applications. 
1.3 Control of DNA’s functions by light 
There exists a large effort directed to develop biomolecular tools to control biological 
processes using external stimuli. Over the last two decades several external stimuli were 
investigated to regulate the replication, transcription and translation processes of genes. 
Amongst the variety of stimuli such as light, pH, electric field and heat, light is the most 
promising. This is due to many reasons such as using light is efficient, clean and does not 
produce any contaminants that could affect the biological system and the facile synthesis 
of various photoresponsive molecules which provide a wide range of excitation 
wavelengths.  
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Photoresponsive molecules are defined as molecules that undergo predictable changes in 
response to light. They are classified as photocleavable and photoswitchable molecules, 
also known as photochromic molecules. Examples of photocleavable moieties are 
hydroxylphenylacyl, coumarin and o-nitrobenzyl derivatives (Fig. 1-7). o-Nitrobenzyl 
derivatives have been widely used due to its stability in synthetic and biological 
environments. Because the photocleavable processes are irreversible, photoswitchable 
molecules are preferable. Photochromic molecules are molecules that undergo structural 
rearrangement between two or more isomeric forms in response to irradiation. The 
direction of this arrangement is determined by the wavelength of the incident light.  
 
Figure ‎1-7: Photocleavable moieties for photoregulation of biological activity. 
There are several classes of photochromic molecules as azobenzenes, stilbenes,
4
 
diarylethenes,
5 
 thioindigo derivatives,
6 
fulgides
7
  and spiropyrans.
8
 The structures are 
illustrated in (Fig. 1-8). In all cases, the photoisomerization process is reversible; while 
after repeated isomerization cycles a fatigue can set. In our work we are interested in 
azobenzene as photochromic molecule.  
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Figure ‎1-8: Different classes of photochromic molecules. 
1.4 Azobenezene 
Azobenzene, is an organic molecule consisting of two phenyl rings linked together with 
azo group (N=N) in which each nitrogen atom carries a non-bonding pair of electrons. 
Azobenzene was used for the first time in 1879,
9a-b
 and initially was used as a dye. It is 
currently employed in 60-70 % of the dye industry.
10
 
 Recently, the isomerization properties of azobenzenes were rediscovered and have been 
exploited in many applications such as optical data storage,
11
 liquid crystal display,
12  
molecular machines design
13
 and many biochemical activities.
14-a-b 
All these applications 
are based on its ability to undergo geometrical trans-cis isomerization in response with 
light. 
1.4.1 The UV/Vis spectroscopy of azobenzene 
To have a full understanding of the spectroscopy of azobenzene, knowledge of its excited 
states is essential. Cis- and trans azobenzene have three excited single states attributed to 
three absorption bands that appear in the visible and near UV regions as shown in (Fig. 1-
10a and 1-10b).
15a-b
 In the azobenzene system, there are three types of electronic 
transitions: 1) The lowest-energy transition is that obtained due to the forbidden ns1* 
transition which corresponds to the S0S1, this transition appears in the visible region at 
approximately 430 nm and 440 nm for cis and trans isomers, respectively. 2) Transition 
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that occurs due to symmetry-allowed 11* transition corresponding to the S0S2 
which appears in the UV region at 280 nm and 314 nm for cis and trans isomers 
respectively and 3) the highest-energy transition due to * transition that occurs at 
the region 230-244 nm are for cis and trans isomers. The presence of an electron 
donating substituent in ortho or para positions as (OH or NH2) to the azo group leads to 
decrease the energy of -* transition and consequently the -* absorption band shifts 
to longer wavelength. Generally, the greater the electron donating substituent the greater 
the bathochromic shift.  For example, the presence of dimethylamino group in para 
position of azobenzene ring decreases the -* energy more than p-amino group and 
thusly appearing at longer wavelength. Another example of azobenzene analogues is 
pseudostilbene (Fig. 1-9), an azobenzene system which contains an electron donating and 
electron accepting group in resonance at the para positions. The presence of the donating 
and accepting groups leads to a reduction of the energy of -* transition and 
consequently its appearance at longer wavelengths. 
 
 
Figure ‎1-9: Different examples of azobenzenes and effect of substituents on the 
absorption bands. D and A represent  donor and acceptor groups substituted.    
 
 
 
 
 
 
 
Figure ‎1-10: a) Molecular orbital diagram for  azobenzene system, adapted from 
ref.
15b
 b) UV-VIS spectrum of  trans and cis azobenzene in ethanol at room 
temperature.  
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1.4.2 Photoisomerization of azobenzene 
Azobenzene can undergo geometrical structural change from trans to cis isomer, and 
reverse, in response to optical excitation with light at suitable wavelength. As shown in 
(Fig. 1-11), trans to cis isomerization takes place via excitation with UV light at 
(300>>400 nm), while upon excitation of cis-form with visible light (> 400 nm), or 
thermally, the trans isomer is recovered. The trans isomer is a conjugated planar 
molecule and its  electrons can be delocalized over the entire molecule therefore it is 
thermally stable while in the cis isomer there is a steric clash between the two phenyl 
rings which forces the molecule to have a skewed conformation and consequently it is 
less stable than the trans isomer. The trans-to-cis photoisomerization process is seen to 
be accompanied by a structural change in which the distance between para carbon atoms 
in azobezene decreased from 9Å in trans isomer to 5.5 Å in the cis isomer.
16
 This change 
in geometry is the cornerstone for various azobenzene applications. 
  
 
Figure ‎1-11: Photoisomerization of azobenzene in response with UV/Visible light. 
As shown in (Fig. 1-12), after excitation of the trans isomer with light of suitable 
wavelength, it will decay to either the ground state (S0) of trans or that of cis isomer. 
Similarly, upon excitation of the cis isomer a relaxation to either the ground state (S0) of 
cis or trans occurred. The decaying of the cis isomer may take place thermally to the 
trans isomer. A photostationary state (PSS), an equilibrium state between the rates of 
excitation and relaxation of the cis and trans isomers, can be reached when both cis and 
trans isomer absorb radiation of the same frequency. Due to the absorbance spectra of 
trans and cis azobenzene are quite different, the photoisomerization process can be 
followed by UV/Vis spectroscopy. The ground state energy of trans isomer at room 
temperature was found to be lower than the cis-azobenzene by an estimate 11.8-13.8 
11 
 
kcal/mol.
17a-b
 and the energy barrier to reach cis isomer was found to be 36.9 kcal/mol.
18
 
Consequently, in the dark the more thermally stable trans isomer is found to 
predominate.  
 
Figure ‎1-12: Excitation and relaxation routes of trans and cis azobenzene isomer. 
1.4.2.1 The photoisomerization mechanism 
The mechanism of the photoisomerization of azobenzene has been a longstanding debate 
in the literature. There are two proposed pathways for this process to take place either by 
a rotation or inversion mechanism
19a-e  
as illustrated in
 
(Fig. 1-13). Rotation mechanism 
involves a torsion of the N=N bond around the dihedral angle (, CN-NC), while 
inversion mechanism involves an in-plane inversion of the angle () around the azo group 
and one of the attached carbon of the benzene ring (NN-C). Despite the numerous reports 
investigating the photoisomerization mechanisms of azobenzene, there has been no 
agreement on which pathway the photoisomerization takes.  
12 
 
 
Figure ‎1-13: The proposed mechanisms for the isomerization of trans to cis 
azobenzene. 
1.4.2.2  Thermal cis to trans isomerization. 
Similar to the photoisomerization, the thermal isomerization cis to trans is agreed to take 
place via rotation mechanism or inversion mechanism as shown in (Fig. 1-14). Although 
both mechanisms are viable,
20
 more studies support the rotation mechanism.
21a,b
 Thermal 
isomerization of azobenzenes is dependent on various factors as solvent polarity, 
substitution on the aromatic ring and pH of the medium. Subjecting azobenzene to acidic 
condition catalyzes the thermal isomerization via formation of an azonium protonated 
intermediate and thus the –bond of N=N is ruptured and consequently facilitates the 
rotation around the N-N via rotation mechanism.
22
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Figure ‎1-14: Proposed mechanism for cis to trans thermal isomerisation in 
azobenzene adapted from ref.
 21b 
1.4.3 Utility of azobenzene as quencher 
During the last two decades DNA detection has attracted much attention due to its 
potential applications in disease treatment. The most common method for DNA 
hybridization detection is molecular beacon technology
23
 (MB) which involves labeling 
of DNA probes with fluorescent dyes and quenchers. This approach relies on the design 
of the labeled probes. 
One example of an azobenzene derivatives used as a quencher is p-aminoazobenzene. It 
has been tested for quenching the fluorescence signal of Bovine Serum Albumin (BSA) 
protein,
24
 a protein that responsible in the transport and disposition of endogenous and 
exogenous compounds present in blood. It is known that BSA has two tryptophan 
residues Trp-212 and Trp-314 which possess intrinsic fluorescence.  At physiological pH, 
it was found that the fluorescence intensity of BSA was quenched gradually with the 
increase of p-aminoazobenzene concentrations accompanied with blue shift of the 
maximum emission wavelength up to 7 nm. 
14 
 
 4-(N,N-Dimethylamino)azobenzene-4-carboxylic acid (DABCYL) is another example 
of an azobenzene-based quencher (Fig.1-15). It is characterized by an absorption 
maximum at 475 nm and it has quenching range from 400-550 nm. This property has 
allowed its use to quench a wide range of common fluorescent dyes such as 5-((2'-
aminoethyl)amino)naphthalene-1-sulfonic acid (EDANS) (em= 490 nm), carboxy- 
fluorescein (FAM) (em=520 nm), tetrachlorofluorescein (TET) (em= 535 nm), 2',7'-
dimethoxy-4',5'-dichloro-6-carboxyfluorescein (JOE)(em= 548 nm) and hexachloro- 
fluorescein (HEX) (em= 550 nm). The quenching ability of DABCYL molecule was 
intensively investigated in numerous biological systems with oligonucleotides (for 
nucleic acid detection or peptide for monitoring enzymatic activity.
25 
 
 
Figure ‎1-15: Structure of the universal quencher DABCYL. 
1.4.4 Some of biological applications based on azobenzene 
photoswitching 
Azobenzene has proven to be a useful tool for switching activities in biological systems. 
This is mainly due to three reasons: azobenzene chemistry is well established, 
photoisomerization of azobenzene is reversible and photoisomerization can easily be 
achieved by shining light on the azobenzene-based biological system to be regulated. 
Azobenzene photoregulation was extensively investigated in various biological systems 
as peptides, enzymes, ion channels and oligonucleotides.  
1.4.4.1 Photoregulation of peptides by azobenzene 
Azobenzene derivatives were employed to photo-induce random/-helix transitions in 
polypeptides. The first example of polypeptides containing photoisomerizable 
azobenzene chromophore were reported by Goodman,
26a,b 
who used phenylazophenyl 
alanine for photoregulation of polypeptides.  
15 
 
To follow the variation of polypeptide structures corresponding to the photoisomerization 
of tethered azobenzene, circular dichroism (CD) was used. It was the most effective 
technique since the various polypeptide structures, random coil, -helix and -structure 
have a characteristic circular dichroism spectra. Pieroni and coworkers
27a,b 
reported the 
incorporation of azobenzene into the side chain of poly(L-glutamic acid). In organic 
solvents as trifluoroethanol or trimethyl phosphate (TMP), the azo-based polypeptide has 
been confirmed by CD to exist in -helix structure. Upon illumination at 350 nm to 
produce trans-to-cis photoisomerization, no change in CD spectrum was observed. This 
indicates, under these solvents, light does not induce any variation in the main-chain 
structures. While in water at critical pH values,
28
 20% azo-modified poly(L-glutamic 
acid) exhibited CD spectra attributed to random coil structure and upon irradiation no 
change in the CD was observed. By the addition of surfactant dodecylammonium 
chloride (DAC)
27b
 at its critical micelle concentration, the CD spectrum confers the 
random coil structure. Upon exposure to light at 350 nm, CD spectrum confirms 
switching of the azo-modified polypeptide from random coil to up to 30% -helix 
structure. A complete conversion from -helix to random coil transition was obtained by 
irradiation of the sample at 450 nm or thermally in the dark.  
The effect of trans-to-cis isomerization of azobenzene derivatives has been investigated 
by photoinducing the helical sense of poly(L-aspartate).
29a-c 
In 1,2-dichloroethane, the 
poly(L-aspartate) with high content of azo units has been confirmed to exist in left-
handed helical structure and upon irradiation with uv-light at 350 nm, a transition to 
right-handed helical structure was observed. It was found that using solvent mixtures as 
1,2-dichloroethane: trimethyl phosphate (TMP) (75:25%) induces a large photorespon- 
sive effect even at a low content of azo units. 
 
Another example of photoregulation of cyclic peptide by azobenzene was reported by 
Vollmer and coworkers,
30
 they designed a peptide system composed of two cyclic 
octapeptides with alternating D- and L--amino acids linked by an azobenzene linker as 
shown in (Fig. 1-16). Azobenzene is known to be exist in the more thermally stable trans 
isomer and thus the peptides were assembled in high-order oligomers due to 
16 
 
intermolecular hydrogen bonding between the peptides. Upon irradiation with UV light at 
366 nm, a conversion from intermolecular assemblies into single intramolecular 
hydrogen bonded species was observed due to trans-to-cis isomerization and recovery of 
trans isomer was obtained via irradiation with visible light. The photoisomerization of 
the azobenzene-based cyclopeptide was completely reversible in both directions.  
 
 
 
Figure ‎1-16: Photoisomerization of azobenzene-based cyclic peptides. Upon UV 
irradiation, a conversion from intermolecular assemblies (trans form) into single 
intramolecular hydrogen bonded species (cis form) was obtained. 
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1.4.5 Photoregulation of enzymatic activities by azobenzene 
 
Azobenzene has been widely used for reversible switching by light between alternative 
conformations of peptides and proteins. Different approaches have been used to introduce 
azobenzene into peptides and proteins such as, incorporation during peptide synthesis,
31a,b
 
incorporation during in vitro translation,
32
 incorporation in vivo by utilizing an 
orthogonal tRNA/aminoacyltRNA synthetase pair (specific for phenylalanine-4`-
azobenzene
33
) and through chemical modification of peptides and proteins.
34
 Photo- 
regulation of enzyme activities has been achieved for numerous kinds of enzymes as 
phospholipase,
33
 papain, -chymotrypsin, RNase S.35 
-Chymotrypsin and papain catalyze the cleavage of peptide bonds, controlling the 
enzymatic acitivity of -chymotrypsin and papain by azobenzene was found to take place 
in different mechanisms. -Chymotrypsin36 activity was controlled by 
photoisomerization of azobenzene through immobilizing the -chymotrypsin inside          
a copolymer matrix containing azobenzene moieties. In other words, there was no need to 
directly attach azobenzene unit to the enzyme. Willner and coworkers
37
 have shown that 
photocontrol of papain activity can be achieved in a different way, through 
photoisomerization of covalently attached azobenzene moieties to the lysine residues in 
the enzyme backbone. They believed that the photoisomerization of trans-azobenzene 
units to cis isomers is accompanied with structural changes in the protein backbone and 
consequently affects the binding properties of the enzyme toward the substrate.  
Schierlinga and coworkers
38
 were able to control the activity of restriction enzyme PvuII 
for gene targeting DNA genome at specific sites in vivo. To accomplish this purpose, 
4,4`-bis(maleimido)azobenzene has been used as azobenzene analogue. Azobenzene 
moieties were attached through two cysteine residues between the two halves of the 
enzyme PvuII and thereby cross-linking them. Upon illumination with blue light (450 
nm), an increase in DNA cleavage activity up to 16 fold was observed by changing the 
configuration of azobenzene units from cis to trans.  
18 
 
1.4.5.1 Incorporation of azobenzene to oligonucleotides 
The first example of reversibly photoswitchable oligonucleotides was introduced by 
Yamana and co-workers.
39a,b
 They were able to bind two oligonucleotides via azobenzene 
as a linker, upon irradiation with light at around 350 nm the azobenzene linkers 
efficiently undergo trans-to-cis isomerization. Later, Komiyama’s group incorporated 
azobenzene (Fig. 1-17) to the side chain of DNA oligonucleotides using phosphoramidite 
chemistry. In this study, a short DNA oligomer was synthesized (homothymidine-8mer) 
whereas azobenzene was introduced as a replacement of one nucleoside. In case of trans 
isomer, the melting temperature between the azobenzene containing homothymidine and 
homoadenosine was found to be slightly different from that between unmodified 
homothymidine and homoadenosine by 0.9 C. Upon photoisomerization to cis isomer, a 
reduction of 8.9 C in the melting curve was observed. On the basis of these results 
Komiyama investigated the ability of azobenzene-photoizomerization on the regulation 
of DNA duplex
40 
and triplex.
41 
 
Figure ‎1-17: Structure of azobenzene monomer used in photoregulation of DNA. 
1.4.5.1.1 Photoregulation of DNA transcription by azobenzene 
Asanuma and coworkers
42
 were able to utilize azobenzene in photoregulation of the 
transcription through controlling T7 RNA polymerase reaction (T7 RNAP). At the first 
study, a 20-mer containing the azobenzene residue at different locations as an insertion 
without replacement of any nucleotide was synthesized and a 39-mer was used to form 
the double stranded T7 promoter (Fig. 1-18). It was found that upon illumination with 
visible light, the azobenzene units exist in the trans isomer, the transcription rate was 
suppressed by 10% relative to the control reaction. While by irradiation with UV light the 
cis isomer was generated and consequently the transcription rate was increased. They 
19 
 
explained the effect of trans to cis photoisomerization on the transcription by that when 
azobenzene exist as trans configuration can intercalate between the DNA double strands 
and thus maintain the DNA duplex. By switching trans to cis isomer, the azobenzene 
disturbed the DNA duplex and thus facilitates the transcription reaction. The regulation 
of transcription was found to be dependent on the azobenzene unit location. The highest 
efficiency of transcription photoregulation was achieved when azobenzene unit was 
located between the 10
th
 and 11
th
 nucleotides of the non template strand. The T7 promoter 
has two functional regions known as loop binding region and the unwinding region. 
Later, it was found that the introduction of two azobenzene residues into the nontemplate 
strand of the T7 promoter whereas one at position-9 (in the loop binding region) and at 
position-3 (in the unwinding region) afforded 7.6 fold increase in transcription rate after 
irradiation with UV light (Fig.1-18b).
 43
  
 
Figure ‎1-18: Photoswitching of transcription using T7 RNA polymerase. 
1.4.5.1.2 Control RNase H activity by azobenzene 
RNase H, is an enzyme which hydrolyzes RNA only when it is hybridized to the 
complementary DNA. Komiyama and coworkers
44
 have investigated the control of 
20 
 
RNase H activity through the photoisomerization of azobenzene. In their study, a model 
of a 20-mer sense RNA strand was designed to hybridize to 20-mer native antisense DNA 
strand and another 20-mer sense DNA strand containing five azobenzene residues as 
extra residues. As illustrated in (Fig. 1-19), at the beginning the azobenzene containing 
antisense DNA strands was hybridized with DNA sense forming a stable duplex (Tm = 
60.8 C in the trans form). Upon illumination with UV light, the cis isomer was produced 
and thus the duplex was destabilized (Tm = 42.6 C) and consequently the antisene DNA 
strand is released due to the instability of the sense/antisense duplex and is hybridized to 
the RNA strand, thusly RNA strand was subjected to digestion by RNase H. It was found 
that the RNase H activity was increased by 3 fold after UV irradiation.  
 
Figure ‎1-19: Photoregulation of RNase H activity. 
1.4.6 New properties of azobenzene 
It is well known that azobenzene derivatives are not inherently fluorescent which is 
ascribed to the high efficiency of trans-cis photoisomerization. Kawashima and 
coworkers
45a,b
 reported the synthesis of an azobenzene fluorescent molecule by 
21 
 
incorporating bis-pentafluorophenyl borane moiety at an ortho position of azobenzene as 
shown in (Fig1-20). With varying donor/acceptor groups at para positions of azobenzene 
led to azobenzenes characterized by its ability to emit green, yellow, orange and red 
fluorescence. The fluorescence property of boron-based azobenzene derivatives is due to 
the coordination of boron atom with the lone pair of azo nitrogen atom and thusly, the 
isomerisation around the azo bond is restricted and consequently upon excitation of 
boron-based azobenzene derivatives, the photoismoerization pathway is less favoured. 
 
Figure ‎1-20: Fluorescent azobenzene due to B-N interaction. 
Furthermore, Siewersten and coworkers
46a,b
 were able to tune the photoswitching 
wavelength of azobenzene. They have designed an azobenzene derivative with 
unexpected properties characterized by an ethylene bridge which connects the two phenyl 
rings at the ortho position. As shown in (Fig. 1-21), this design strains and disrupts the 
trans isomer, therefore, the cis isomer become the more thermally stable. They were able 
to obtain the trans-to-cis photoisomerization with green light irradiation (480-550 nm) 
with efficiency close to 100% due to the effect of ethylene bridge, while cis -to-trans 
photoisomerization occurs with near UV light ( 380-400 nm). 
 
 
Figure ‎1-21: Bridged azobenzene  
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1.5 Goals of this thesis  
The aim of this thesis was to develop novel quenchers for labeling fluorescent 
hybridization probes that may used for the detection of DNA mutations. 
Since 4-(N,N-dimethylamino)azobenzene-4-carboxylic acid (DABCYL) is a common 
quencher that used for labeling fluorescent probes, we aimed to introduce it into peptide 
nucleic acid (PNA).  The 4-(N,N-dimethylamino)azobenzene moiety may be introduced 
into PNA as a nucleobase replacement and evaluation of its quenching and photoresponse 
abilities can be done. The quenching efficiency of the 4-(N,N-dimethylamino)- 
azobenzene moiety  was evaluated  in a PNA molecular beacon design.  
Furthermore, because of azobenzene molecule is not able to participate in the hydrogen 
bond network with nucleobases, we aimed to introduce a novel uracil-based quencher 
that mimics the structure of the universal quencher DABCYL. The modified uracil is 
designed to have 4-(N,N-dimethylamino)phenylazo moiety at C5 which does not interfere 
with hydrogen bonding sites of uracil and therefore retain the base pairing ability with 
adenine.  
There are several advantages of the synthesis of modified uracil analogue with intrinsic 
quenching ability such as it may use as a quencher in molecular beacon probes, 
possibility to attach the modified uracil at any position of the designed oligomer and 
therefore may lead to increase the stability of the formed duplex with the complementary 
nucleic acid and finally, the presence of phenylazouracil moiety that can undergo 
configurational change upon excitation with light at certain wavelength may lead to its 
use in photoregulation of  the formed duplex between oligomer that contains the modified 
uracil and the complementary nucleic acid sequence.  
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Chapter 2  
2 Synthesis and Photophysical Studies of Azo-Based Quencher 
for PNA-Molecular beacon 
Using fluorescent probes for nucleic acid detection has attracted much attention due to its 
efficiency, ease of synthesis and availability of commercial reporters that facilitate the 
probe synthesis. Nucleic acid detection takes place by changing either the intensity of the 
reporters fluorescent signal or the colour of its fluorescence. In this chapter, we describe 
the synthesis of a peptide nucleic acid monomer carrying an azobenzene unit and 
evaluation of its photoisomerization and quenching properties. In the following section a 
brief overview on the origin of fluorescence and mechanism of fluorescence generation in 
different types of fluorescent hybridization probes will be given.  
2.1 Fluorescence 
Luminescence is a spectrochemical process that involves the emission of light as a result 
of irradiating a molecule at certain wavelength. This process is due to the molecule 
absorbing photons and consequently being excited to higher electronic states. When 
relaxing back to the ground state, it accompanied with emission of light. Light emission 
usually takes place at longer wavelength due to loss of some of its energy as heat. The 
difference between the maximum absorption and maximum emission is known as Stokes 
shift referred to Sir. G. G. STOKES who described this phenomena.1   
Luminescence is divided into two major types, fluorescence and phosphorescence 
depending on the electronic states that photons are relaxing from as singlet (S) or triplet 
(T) states, respectively, as shown in simplified Jablonski diagram (Fig. 2-1). There are 
two important features that distinguish fluorophores: 1) fluorescence quantum yield and 
2) life time.  Fluorescence quantum yield (F), is the ratio of absorbed photons to emitted 
photons. In other words, fluorescence efficiency is determined by the fraction of excited 
molecules that can emit light when relaxing from excited state by fluorescence rather 
than any of non-radiative mechanism.  
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Figure ‎2-1: Jablonski diagram illustrated luminescence origin.  
2.2 Fluorescence resonance energy transfer (FRET) theory      
         and fluorescent hybridization probes 
Several types of fluorescent probes have been reported and they are all labelled with at 
least one fluorophore. Upon excitation of that fluorophore at an appropirate wavelength, 
it will be excited from the ground state to a higher excited single state. Relaxation of 
fluorophore back to lowest singlet state is accompanied by the emission of light. Most 
fluorescent detection protocols are based on the ability of nearby molecule, another 
fluorophore or non-fluorescent molecule, to decrease the intensity of fluorescence. 
Mainly, there are two mechanisms for fluorescent signal quenching, contact quenching 
and fluorescence resonance energy transfer (FRET).  In contact quenching mechanism, 
an interaction between the donor (fluorophore) and the acceptor (fluorophore or 
nonfluorescent molecule) is mediated through hydrogen bonding “called proton-coupled 
electron transfer” forming non-fluorescent complex. The characteristic feature of contact 
quenching mechanism is the absorption spectral change of the donor and acceptor at the 
time of complex formation.  
Fluorescence resonance energy transfer (FRET) mechanism, also called (Förster 
resonance energy transfer),
2 
 involves the transfer of the excitation energy to a nearby 
acceptor in non-radiative fashion through energy exchange of the donor oscillating dipole 
with an acceptor dipole that has similar resonance frequency. 
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There are two main strategies behind the design of FRET probes for biological studies. 
One is by designing the probe by using two fluorescent dyes. In this type a donor 
fluorescent dye is irradiated at its excitation wavelength and by FRET, the excitation 
energy is transferred to the acceptor fluorescent dye and consequently it is excited and 
emits light at its characteristic emission wavelength. Alternatively, a probe can carry a 
donor fluorescent dye at one terminus and nonfluorescent molecule which acts as 
acceptor, called a quencher, at the other end. Quenchers are molecules capable of 
quenching the fluorescent signal without emitting light. The efficiency of FRET relies on 
the distance between the donor and acceptor and the extent of spectral overlapping 
between absorption spectra of acceptor with the emission spectra of the donor as shown 
in (Fig. 2-2). The effective distance between the donor and acceptor is in the range of 10-
100Å
3
 which is roughly equal to the distance between 3-30 nucleotides in DNA duplex. 
The extent of spectral overlap is determined by Förster radius (RO) and FRET efficiency 
(E) can be determined from equation (Eq. 2-1).  
                                    E =(1+R
6
/Ro)
-1                                                                              
(Eq. 2-1) 
Where R is the distance between the donor and acceptor, Förster radius for a given donor-
acceptor pair, is conducted from equation (Eq.2-2).  
                                 Ro = 8.8 x 10
-28 F k
2
n
-4
J (v)                                                   (Eq. 2-2) 
Where F is fluorescence quantum yield of the donor in the absence of the acceptor, n is 
the refractive index of the medium, K
2 
is a parameter that depends on the relative 
orientation of the donor and acceptor transition moment and J(v)is the spectral overlap 
between the donor emission  and the acceptor absorption. 
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Figure ‎2-2:  Resonance energy transfer Jablonski diagram and spectral overlap  
                     donor emission spectra with acceptor absorption spectra. 
2.2.1 Examples of fluorescent hybridization probes using FRET 
mechanism  
2.2.1.1 Adjacent probes or (Light Cycler™ hybridization probe) 
In this technique, two single-stranded hybridization probes are designed in a way that 
they bind to neighboring sites on the target nucleic acid. The donor is attached to one 
probe at the 3`end while the other probe is labeled with acceptor at 5`end. Upon 
hybridization with the target, the donor and acceptor are located at a distance allows 
FRET to take place (Fig. 2-3).  
 
 
 
Figure ‎2-3: Schematic representation for adjacent probes. 
2.2.1.2 5`-Nuclease probes or (TaqMan® probes) 
A 5`-Nuclease probe is single-stranded probe labeled with a donor at one end and an 
acceptor at the other end and is amenable to 5`-nuclease digestion. This probe is 
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designed as polymerase chain reaction primer in addition to the complementary 
sequence for the target DNA. Upon hybridization to the target, DNA polymerase 
extends the primer and consequently digestion of the probe by 5-nuclease is obtained. 
As a result of the cleavage, the donor and acceptor are separated and consequently the 
fluorescence signal intensity is increased as shown in (Fig. 2-4)  
  
 
 
Figure ‎2-4: Schematic representation for 5`-nuclease probes. 
2.2.1.3 Strand-displacement probes (or Yin-Yang probes) 
In this technique, two complementary sequences are used whereas one sequence is 
labeled with donor and the other is labeled with quencher (nonfluorescent molecule). 
When the two probes are hybridized to each other forming a duplex, the fluorescence 
signal is quenched. In the presence of the target DNA, it binds with one of the two probes 
forming more stable hybrid and consequently the two labeled probes being separated 
leading to increase in fluorescence intensity (Fig. 2-5). 
  
 
Figure ‎2-5: Schematic representation for strand-displacement probes. 
2.2.1.4 Molecular beacon 
Molecular (MB) beacon technology,
4 
one of the applications that used fluorescent probes 
in nucleic acid detection. A MB is a single stranded nucleic acid probe labelled with a 
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fluorescent dye (donor) in one end and a dye (acceptor) at the other end. MB probe 
design consists of three main domains: stem, loop and fluorophore/quencher pair. This 
design forces the fluorescent dye to be in close proximity to the quencher as illustrated in 
(Fig. 2-6). It was found that for PNA, a MB hairpin structure is not required to bring the 
quencher in close proximity to the fluorophore,
5
 therefore it is called a stemless PNA-
MB. The probe sequence is chosen to be complementary to a specific target sequence that 
is present in the nucleic acid to be detected. When the fluorescent dye is excited the 
energy is transferred to the quencher through fluorescence resonance energy transfer 
(FRET) and therefore no emission is observed. Upon hybridization with the 
complementary single-stranded DNA target, the quencher is located farther from the 
fluorescent dye and as consequence the fluorescence signal is produced.  Most MB 
probes are between 25 and 40 nucleotides long in which the recognition sequence (loop) 
usually consists of 15-30 nucleotides and the stem is formed by 5-10 base pairs. 
 
 
 
Figure ‎2-6 : Schematic representation for molecular beacon. 
There are a plethora of commercially available fluorophores that are commonly used for 
labeling fluorescent hybridization probes such as fluorescein derivatives: 5-
carboxyfluorescein (F) and 2',7'-dimethoxy-4',5'-dichloro-6-carboxyfluorescein (JOE) 
and rhodamine derivatives as :  N,N,N',N'-tetramethyl-6-carboxyrhodamine (TAMRA); 
6-carboxy-X-rhodamine (ROX) and 6-carboxyrhodamine (R6G). For example, quenchers 
that are commonly used are DDQ-1, Black hole quenchers (BHQ), Eclipse and Dabcyl 
(Fig. 2-7). The choice of fluorophore quencher combinations is mainly based on the 
emission range of the fluorophore that should overlap with the absorption range of the 
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quencher to facilitate the transfer energy from the fluorophore to the quencher via FRET 
and consequently quench the fluorescence of the fluorophore 
 
Figure ‎2-7: Examples of fluorophores and quenchers have been used in fluorescent   
                         probes. 
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2.3 Peptide nucleic acid (PNA) 
Since many human diseases are related to genetic perturbations, detection of mutations 
has become an essential mission for scientists to accomplish. There are many causes 
contributing to the differences in sequences such as single nucleotide polymorphisms 
(SNP) or other sequence alterations such as point mutations, insertion and deletions. 
SNPs are considered the most common type of genetic variation among people, and their 
detection has attracted much attention.  
Several techniques have been developed to detect SNPs based on nucleic acid probes 
tagged with a fluorescent moiety as a reporter. Currently, the utility of the fluorescent-
based probes in SNP detection is the most common strategy due to their safety.
6
               
A remarkable example of probes that have been used is peptide nucleic acids (PNAs). 
PNA, a DNA analog, was invented 20 years ago by Nielsen.
7 
It consists of a pseudo 
polypeptide backbone that is comprised of repeating N-(2-aminoethyl)glycine units and 
nucleobases are attached to the backbone via a methylene-carbonyl linker as illustrated in 
(Fig. 2-8). Unlike natural nucleic acids, PNA does not contain phosphate groups and 
therefore it possess a neutral character which provide stronger binding between PNA and 
its complementary nucleic acid than that between DNA: DNA and DNA: RNA at low to 
medium ionic strength.  
The PNAs are depicted like peptide, from the N-terminus to the C- terminus, when the N-
terminus of the PNA faces the 5'end of the DNA or RNA the complex is termed parallel. 
Formation of duplexes can be obtained in both parallel and anti-parallel orientations but 
the anti-parallel is strongly preferred. In addition, due to PNA’s artificial character they 
show the ability to resist nuclease or protease degradation and consequently possess 
extended lifetime both in vivo and in vitro.
8
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Figure ‎2-8: Comparison between DNA and PNA structures. 
 
2.3.1  PNA binding modes with nucleic acids (NAs) 
PNA forms stable duplexes with single stranded-nucleic acids similar to DNA:DNA and 
DNA: RNA obeying Watson-Crick base pairing rules. PNA may bind to the double 
stranded-DNA through different types of binding modes
9 
as illustrated in (Fig. 2-9). PNA 
binds with double stranded-DNA forming classical triplexes via Hoogsteen base pairing 
and this type of binding requires a high cytosine content of the PNA
10a,b 
(Fig. 2-9. A). 
Homopyrimidine PNAs bind to the complementary DNA forming (PNA)2:DNA via 
triplex invasion
10a,b
 through opening the DNA double helix and one PNA strand binds to 
DNA obeying Watson-Crick base pairing rules and the other PNA binds through 
Hoogsteen base paring  (Fig. 2-9B).  
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Figure ‎2-9: Binding modes of PNA with double-stranded DNA. 
Thymine is able to engage with adenine by Hoogsteen pairing, while cytosine requires 
protonation which occurs below physiological pH to form stable Hoogsteen base pair 
with guanine. Such pH dependence limits this binding and this limitation can be avoided 
by replacing cytosine with pseudoisocytosines(IC) J-base12  or N7-guanine.13 PNA 
with high purine content can bind with double-stranded DNA forming duplex invasion 
via opening the DNA duplex helix followed by invasion of PNA (Fig. 2-9C). Finally, it 
was found that PNA has the ability to bind to DNA duplex via double duplex invasion by 
using modified nucleobases in the PNA strands pseudo complementary PNAs  In this 
type of binding, the DNA target should contain at least 50% of AT and all A/T base pairs 
in PNA strand are replaced with 2,6-diaminopyrimidine/2-thiouracil base pair. The 
presence of 2,6-diaminopyrimidine/2-thiouracil base pairs in PNA prevents binding of 
the two PNA stands to each other due to the steric hindrance. Thusly, they bind only to 
the target DNA (Fig. 2-11). PNA has shown a high binding affinity and specificity for 
nucleic acids, therefore, it is considered a very interesting and potentially useful tool in 
molecular biology, and may have both diagnostic and therapeutic applications.
14a-c 
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Figure ‎2-10: Triplex invasion of double helix DNA by homopyrimidine PNA 
oligomers. a) Protonated cytosine for Hoogsteen base pairing, replacing all cytosines 
with   b) pseudoisocytosines (J) or c) N
7
-guanines in the Hoogsteen strand to avoid 
low pH required for N3 protonation. 
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Figure ‎2-11: Double duplex invasion of DNA by pseudo complementary PNAs. 
2.3.2 PNA modifications 
Despite the attractive and interesting properties of PNA, a number of drawbacks have 
been observed such as poor solubility,
15
 tendencies to self aggregation and poor cell 
permeability.
16
 These limitations motivated researchers to modify the aminoethyl- 
glycine (aeg) PNA structure. A large number of PNA analogues have been synthesized 
through different types of modification on the backbone and/or nucleobases. A numerous 
chemical modifications on the aminoethylglycine backbone have been obtained,
17
 only 
few have shown a practical interest such as the lysine derived backbone (Fig. 2-12). 
Introduction of few lysine based monomer provides the PNA with cationic charges and 
thus increase the aqueous solubility of the PNA. In addition, different chemical 
modifications on nucleobase have been carried out to introduce a new functional group to 
the PNA and thus new properties as luminescence, potential-helix stabilization.
18a-c
 
Furthermore, some of non natural nucleobases have been incorporated in PNA oligomers, 
as pseudoisocytosines (IC) as mentioned before it mimics the N3-protonated cytosine 
(Fig. 2-13).  
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Figure ‎2-12: Selected examples of modified PNA backbone. 
 
 
Figure ‎2-13: Selected examples of modified PNA nucleobases. 
2.3.3 Synthesis of PNA oligomers 
The synthesis of PNA oligomers relies on traditional solid phase peptide synthesis 
protocols (SPPS). Solid phase methodology has many advantages over the conventional 
synthesis as: 1) utility of excess reagents drives reactions to completion and resulting in 
increasing the reaction yield, 2) removal of reagents simply carried out by washing, 3) 
due to the product is synthesized on the resin, the handling loss of the product was 
minimized, 4) can be automated. On the basis of these remarkable advantages of solid 
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phase, the synthesis of polypeptides on support through a repetitive synthesis cycles was 
possible. 
The synthesis of first PNA was reported by using Boc strategy that was heavily used in 
peptide synthesis. This protocol relies on using tert-butyloxycarbonyl (tBoc) group to 
protect the free amino group of PNA monomer backbone and benzyloxycarbonyl (Z) 
group to protect the exocyclic amino group of A, C and G nucleobases. The differential 
acid liability between tBoc and (Z) group facilitates the PNA synthesis whereas tBoc 
group is removed by trifluoroacetic acid (TFA) and Z groups are removed using 
trifluoromethane sulphonic acid (TFMSA). Cleavage of PNA oligomer from the solid 
support usually carried out with hydrogen fluoride (HF). In Boc protocol, usually acid 
labile resins as PAM (name is derived from the linker 4-(oxymethyl)phenyl- 
acetamidomethyl) which produces carboxylic C-terminal or MBHA (methylbenzhydryl- 
amine) that produces amide C-terminal.  
Some drawbacks were observed in this protocol such as during the deprotection of tBoc 
with TFA neither remove of side-chain protective groups nor a cleavage of the peptide 
from the resin was observed and therefore reducing the yield of the desired oligomer.  
Another disadvantage of tBoc protocol is the need for hazardous chemicals such as HF 
and the harsh condition for removal of Z group, that highlighted the need for new 
methodology to avoid such limitations. To avoid the repetitive acid treatment of the 
growing peptide in tBoc protocol, a milder method for the synthesis of the peptide with 
the solid phase technique was developed. This method based on introduction of base 
labile N-protecting group. Atherton and Shepard
18
 developed a convenient solid phase 
protocol for peptide synthesis based on using fluorenylmethoxycarbonyl group (Fmoc) 
for N-protection.   
In Fmoc methodology, the free amino group of PNA monomer backbone is protected 
with Fmoc group and benzhydryloxycarbonyl (Bhoc) group is used to protect the 
nucleobase exocyclic amino group. Deprotection of Fmoc group carried out under mild 
conditions using 20% piperidine in DMF forming 9-(1-piperidinylmethyl)fluorene and 
piperdine carbamate salt  by-products which are easily detectable spectophotometrically 
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at 300-320 nm
20
 or via measuring the conductivity respectively, which enables the 
automated monitoring of each deprotection step. At the end of the automated synthesis, 
the quality of the synthesis can be assessed by inspection of the chromatogram of all 
Fmoc groups removed during the synthesis cycles. Deprotection of Bhoc group is carried 
out at the end of the synthesis cycle by TFA at the same time with the cleavage of the 
peptide from the resin. Fmoc-based solid phase peptide synthesis protocol has been 
greatly enhanced by the introduction of a variety of solid supports, linkages, and side 
chain protecting groups. The cleavage of the peptide from the resin depends on the type 
of support and linker that have been chosen. Mainly, acid sensitive supports are used for 
Fmoc-mediated protocols as Wang resin also called HMP (4-(hydroxymethyl)- 
phenoxymethyl)polystyrene-1% divinylbenzene resin (produces carboxylic C-terminal) 
or Rink amide (produces amide C-terminal). The release of the peptide from the support 
usually carried out using TFA and purification of the synthesized PNA oligomer usually 
takes place via RP-HPLC and analyzed by mass spectrometry. There are two main side 
reactions that may occurr during PNA synthesis as shown in (Fig. 2-14) firstly, acyl 
migration of the nucleobase acetyl moiety to the N-terminal leaving the secondary amine 
amenable to subsequent coupling giving a PNA with undesired sequence. Secondly, 
intramolecular attack of the primary amine at the N-terminal on the carbonyl group of the 
amide resulting in the lose of the N-terminal as ketopiperazine derivative. Cleavage of 
peptide from resin by TFA and side-chain deprotection can lead to side reactions due to 
reaction of the generated carbocations with the peptides. To overcome this problem, 
scavenger is used to avoid alkylation of the peptide. The choice of scavenger is 
depending on the type of side chain protective groups present. The strategy of solid phase 
synthesis for peptide nucleic acid oligomer using Fmoc or Boc is illustrated in (Fig. 2-
15). 
 
 
 
Figure ‎2-14: Side reactions in PNA synthesis 
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Figure ‎2-15: General strategy for solid phase peptide nucleic acid synthesis. 
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Currently, there are two types of commercially available PNA monomers for peptide 
nucleic acid synthesis. The structures of the protected PNA monomers are illustrated in 
(Fig. 2-16 and 2-17). 
 
Figure ‎2-16: Structures of commercially available tBoc/Z PNA monomers. 
 
Figure ‎2-17: Structures of commercially available Fmoc/Bhoc monomers. 
Several protecting group combinations have been investigated for the synthesis of PNA-
oligonucleotide conjugates as Fmoc/Acyl,
21
Mmt/Acyl
22a,b 
while Fmoc/Mmt
23 
and Fmoc/Z 
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Protecting group strategies were used in the synthesis of PNA-peptide conjugates (Fig. 2-
18). The utility of these protecting groups is limited due to they do not allow orthogonal 
synthesis with commercially available amino acid monomers. Bradley
24
 introduced          
1-(4,4-dimethyl-2,6-dioxacyclohexyl)ethylidene (Dde) group for protecting the terminal 
amino group of the backbone and monomethoxytrityl group (Mmt) for the exocyclic 
amino group of the nucleobases. The Dde group is usually cleaved by hydrazine in DMF 
which also deprotects the Fmoc group. A milder condition for Dde protection was 
developed by Bradley using a mixture of hydroxylamine hydrochloride and imidazole 
under slightly acidic conditions which would be fully orthogonal to the Fmoc group.
24
    
o-Nitroveratryloxycarbonyl group (NVOC)/Acyl
25
 strategy in which NVOC group 
protects the amino group of the backbone was introduced by Liu and it is easily 
photolytically cleaved with irradiation at wavelength > 300nm. Some examples of 
different protecting groups combinations is shown in (Fig. 2-18). 
 
Figure ‎2-18: Examples of various protecting groups in PNA synthesis, protection of   
                      exocyclic amino group in A, G and C (only cytosine is shown for  
                      illustration). 
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2.4 PNA applications  
On the basis of the remarkable high binding and high specificity properties of PNA with 
nucleic acids, PNAs have been employed in various biological applications as diagnostic 
or detection tools in addition to its utility for controlling gene expression. 
 
2.4.1.1 PNA as therapeutic drug 
As described in section 1-1, There are basically two strategies for therapeutic drug 
namely antigene and antisense. Relying on the ability of PNAs to bind with double-
stranded DNA via strand invasion, PNAs have been shown to be a good candidate as 
antigene or antisense agents.
27
 PNAs as antigene tools have been demonstrated its ability 
to arrest transcription processes through formation of triplex complex with DNA via 
strand invasion that confer a structural hindrance and consequently block the activity of 
RNA polymerase.
28
 In vivo, plasmid DNA replication has been blocked by PNA.
29
 In 
vitro, several studies have been demonstrated the ability of PNAs to inhibit DNA 
replication via triplex structure by strand-invaded complexes.
30
  
PNAs as antisense drug, relies on the recognition and binding to the complementary 
sequence of m-RNA through the formation of double helix complex and thus inhibit 
translation of the target gene to protein. Several reports have been introduced to illustrate 
the ability of PNAs as antisense. PNA was able to block liver-specific microRNA (miR-
122) activity in human and rat liver cells.
31a,b
 However, utility of PNAs as tools for 
regulating gene expression was hampered by the slow cellular uptake of PNA by the 
living cells due to its uncharged character. Numerous strategies have been explored to 
improve the efficiency of PNA cellular uptake such as conjugation of PNA with DNA 
oligomers,
32
 ligands as antibodies, steroids,
33a,b 
or peptides such as cell penetrating 
peptides as penetratine.
34
 Incorporation of positively charged residues as lysine or 
arginine into PNA sequence enhanced the PNA delivery. Dragulescu and coworkers 
showed that replacing the glycine side chains in PNA backbone with D-arginines forming 
guanidine-based PNA (GPNA) as shown in (Fig. 2-19) improves the PNA cellular 
uptake
35
 and inhibit protein translation.
36
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Figure ‎2-19: Comparison between the structure of GPNA and aeg-PNA. 
2.4.1.2 PNA for diagnostics and detection 
The excellent hybridization properties of PNAs with nucleic acids have allowed the use 
of PNA in a variety of genetic diagnostic techniques. For example, PNA-fluorescence in 
situ hybridization (FISH) technique. In this technique, a fluorescently labelled PNA is 
used to visualize the complementary nucleic acid target inside the cell. PNA-FISH have 
been used for quantitative telomere analysis,
37a,b
 chromosome painting, bacterial and viral 
diagnostics.
38a,b
 In 2006, advanDx’ PNA FISH probes product for in vitro diagnosis of 
blood was a proved by Food and Drug Administration (FDA) of United States.  
Another powerful application of PNA is PNA directed PCR clamping. In this strategy, 
PNA probes are employed in detection of single base pair mutations or single-nucleotide 
polymorphism (SNPs) by polymerase chain reaction technique (PCR). PNA probe was 
designed to bind to one of the PCR primer sites forming PNA:DNA complex which is 
effectively blocked this sites and hence inhibit amplification of the PCR product.
39a,b
 
Furthermore, PNA used in molecular beacon design,
40
 a description of molecular beacon 
design is introduced in details in (section 2-2.1.4).  
2.5 Results and discussion 
Relying on the aforementioned remarkable properties of both azobenzene (as photoswitch 
and quenching tool) and PNA as diagnostic tools, we have decided to pursue the 
synthesis of PNA-MB bearing azobenzene moiety and assess the quenching ability of 
appended azobenzene moiety against different types of fluorophores that used in 
fluorescence studies. 
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4-(N,N-Dimethylamino)azobenzene has been chosen as azobenzene analog for many 
reasons, azobenzene moiety allows the photoisomerization study for the synthesized PNA 
monomer. The prescence of dimethylamino group which is susceptible to protonation 
facilitates the study of pH effect. Finally, the structure of 4-(N,N-dimethyl- 
amino)azobenezene PNA monomer mimics the structure of universal quencher.               
4-(N,N-dimethylamino)- azobenzene-4`-carboxylic acid (DABCYL) and thus may have 
potential quenching effect. 
 
2.5.1  Synthesis of the backbone 
The synthesis of PNA monomers relies on the assembly of the protected 2-aminoethyl 
glycine backbone and protected nucleobase substituted acetic acid structural units.
41 
We 
aim to synthesize the PNA oligomer using Fmoc protocol for solid phase peptide 
synthesis and therefore synthesis of Fmoc protected PNA monomer is required. 
The synthesis of 4-(N,N-dimethylamino)azobenzene PNA monomer was carried out in 
two steps, synthesis of the tert-butyl-1-(2-(Fmoc)aminoethyl)glycinate backbone and 
nucleobase acetic acid derivative. The Fmoc(aeg)tert butyl ester backbone was obtained 
according to the synthetic route outlined in (Scheme 2-1) following the method reported 
in the literature.
42
 tert-Butyl-1-(2-aminoethyl)glycinate II-1 was obtained by reaction of 
ethylenediamine with tert-butyl bromoacetate in dichloromethane followed by protecting 
the free amino group by N-(9-fluorenylmethoxycarbonyloxy) succinimide (Fmoc-OSu) to 
afford the backbone as oil. Fmoc backbone II-2 was isolated as the hydrochloride salt by 
acidifying the solution with HCl/ether solution. 
 
Scheme ‎2-1: Synthesis of 2-Fmoc(aeg)-t-butyl ester backbone. 
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2.5.2 Synthesis of the dimethylaminoazobenzene PNA monomer 
The synthesis of PNA monomer carrying 4-(N,N-dimethylamino)azobenzene as shown in 
(Scheme 2-2) was obtained via series of chemical transformations started with 
diazotization of p-aminophenylacetic acid followed by coupling with N,N-
dimethylaniline to give 4-(N,N-dimethylamino)azobenzene-4-acetic acid II-3 in 80% 
yield. II-3 was coupled with tert-butyl-N-[2-(Fmoc)aminoethyl]glycinate by 
dicyclohexylcarbodiimide (DCC) mediated coupling to give the tert-butyl ester derivative 
II-4 in 73% yield . Finally, the tert-butyl group was removed by trifluoroacetic acid in 
dichloromethane to afford the azobenzene PNA monomer II-5 in 91% yield.  
  
 
 
 
 
2.5.3 Effect of acid on dimethylaminoazobenzene PNA monomer 
The presence of the dimethylamino group imparts a susceptibility to protonation which 
facilitates the study of pH effects on the azo-based PNA monomer II-5 (halochromism). 
The behavior of 4-(N,N-dimethylamino)azobenzene moiety under acidic conditions have 
been investigated. An ethanol solution of II-5 was titrated with trifluoroacetic acid (0.005 
M).  Upon addition of trifluoroacetic acid, a decrease in the - absorption band for non-
Scheme ‎2-2: Synthesis of azo-based PNA monomer. 
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protonated form at 409 nm with an increase in - absorption band for protonated form 
at 524 nm was observed with isosbestic point at 465 nm as shown in (Fig. 2-20). This 
spectral change is explained with the aid of (Scheme 2-3). Although there are two basic 
sites in azo-PNA monomer II-5, dimethylamino and azo groups,
43
 protonation in ethanol 
favors the lower energy, resonance-stabilized azonium ion over the ammonium ion. 
 
Figure ‎2-20: Changes in the UV-vis absorption spectrum of II-5 in EtOH at 1.66X10
-
5 
M during titration with trifluoroacetic acid, from 0.3 to 2.4 equivalents. 
 
 
 
 
2.5.4 Photoisomerization studies 
Photoisomerization of azobenzene is well established, azobenzene can readily undergo 
conformational change about the azo bond between the trans and cis geometrical isomers 
by light. The trans-isomer can be photoisomerized to the cis-isomer upon illumination 
with UV light (300 < < 400nm), while cis isomers can be converted back to the trans 
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Scheme ‎2-3: Ammonium/azonium protonated ions of dimethylaminoazobenzene. 
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isomer again either by irradiation with visible light ( > 400nm) or thermally. The 
isomerization is completely reversible. 
By using UV/Vis spectroscopy for monitoring the photoisomerization of azo-based PNA 
monomer II-5 in dichloromethane, It was observed that with irradiation of II-5 with UV-
light at 366 nm from hand held source, a decrease in the absorption band centered at 411 
nm with appearance of unexpected large peak at 525 nm similar to the peak observed in 
effect of acids of II-5 study (Fig. 2-20), this may attributed to generation of acid under 
irradiation condition. To circumvent the effect of acid, the irradiation was necessarily 
obtained in the presence of base. Under basic condition, upon illumination of II-5 UV-
light at 366 nm for a period of time, a decrease in the intensity of -* band at 411 nm 
was observed. Recovery of trans-isomer was obtained by heat and it was confirmed by 
growth of the absorption band at 411 nm. (Fig. 2-21) 
 
 
Figure ‎2-21: UV-Vis spectral change of II-5 in dichloromethane. a) under 
irradiation at 366 nm, monitored at the time points shown.  b)  Recovery of the trans 
absorption band at 411nm by heat at rate 1C/min. 
2.5.5 Quenching ability of dimethylaminoazobenzene PNA monomer 
A preliminary, qualitative study to assess the ability of the 4-(N,N-
dimethylamino)azobenzene PNA monomer to quench the emission of fluorescein, pyrene 
and sulforhodamine luminophores was made.  PNA monomer II-5 is an analog of the 
well-established FRET quencher DABCYL. PNA monomer II-5 has a strong, broad 
absorption the spanning the near UV and visible region centered at approximately 410 
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nm in ethanol. This absorbance overlaps with the emission of several commonly used 
fluorophores, when in close proximity, may quench the fluorescence via (FRET). The 
ability of the II-5, to effect intermolecular quenching of representative appropriate 
fluorophores was observed for fluorescein (excitation = 488 nm; emission = 525 nm) and 
pyrene (excitation = 330 nm; emission = 377, 395 and 418 nm) as demonstrated in (Fig. 2-
22).  
The authenticity of the quenching effect observed for fluorophores that matched their 
emission to the absorption band of II-5 was confirmed by using a dye that is not a 
suitable FRET partner:  sulforhodamine.  The sulforhodamine dye is a longer wavelength 
emitting dye (excitation = 550 nm; emission = 595 nm) and is not suitable for use with 
DABCYL.  The results shown in (Fig. 2-22) also indicate that the PNA monomer II-5 
behaves in an analogous fashion as free DABCYL, and does not cause any significant 
fluorescence quenching) The small (overall 7%) decrease in fluorescence intensity is 
likely due to dilution or screening effects. These results provide a direct evidence of the 
quenching ability of the synthesized 4-(N,N-dimethylamino)azo-PNA monomer. 
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A)                                                                              B) 
 
Figure ‎2-22: The effect of increasing amounts of II-5 on the emission spectra of A) 
fluorescein and B) pyrene, 5 mol of each. Spectra were recorded in absolute EtOH 
and room temperature, excitation (fluorescein) = 488 nm and, excitation  (pyrene) = 330 
nm.  
 
 
 
 
Figure ‎2-23: The effect of increasing amounts of II-5 on the fluorescence emission 
spectra of sulforhodamine 640 dye, excitation= 550 nm. Inset, expansion of the peak 
centered at ~590 nm. 
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2.5.6 Design and synthesis of dual-labeled PNA molecular beacon  
In order to assess the quenching ability of the azo-based PNA monomer in biological 
environment, 4-(N,N-dimethylamino)azobenzene unit was incorporated into short 8-mer 
PNA sequence FCTTTTTCAz (II-6), Az is azo-based monomer at C-terminus and F is 
the fluorescein moiety at N-terminus of a molecular beacon design using standard solid-
phase PNA synthetic protocols using Fmoc protected monomers on a lysine-
functionalized Rink amid resin (Nova Syn® TGR). Once the PNA oligomer synthesis 
with uncapped N- terminus was achieved, the resin was divided into two portions, first 
portion was treated with TFA to release the oligomer (II-6) which will be used later for 
hybridization studies to assess the effect of the presence of azobenzene on the stability of 
the triplex formation with the complementary DNA sequence. Fluorescein isocyanate 
Figure ‎2-24: Structures of the fluorophores used in the study. 
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(FITC) was coupled manually to the uncapped N-terminus oligomer-bound resin (second 
portion).  The completion of FITC coupling was confirmed by Kaiser test
44
 and the PNA-
MB (II-7) was purified by reversed phase-HPLC and characterized by MALDI-TOF 
mass spectrometry as shown in (Fig. 2-25 and 2-26).  
 
 
11494 
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Figure ‎2-25: Mass spectrum of azo-based PNA oligomer II-6, calculated 2345.0335, 
found 2345.0468 [MH
+
]
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On the basis of the quenching results that 4-(N,N-dimethylamino)azobenzene PNA 
monomer has proven. Molecular beacon design allows the presence of the azobenzene 
moiety in close proximity to the fluorophore and as a result the fluorescence signal of the 
Figure ‎2-26: Mass spectrum of PNA-MB II-7, Calculated 2735.0772, found 
2735.1440 [MH
+
] 
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Figure ‎2-27: Fluorescence emission spectra (ecitation= 488 nm) of 4-(N,N-
dimethylamino)azobenzene based PNA-MB at 2 M scale under ionic 
condition 100 mM NaCl, 10 mM Na2HPO4, 0.1 mM EDTA, pH 7.0, PNA-
MB-cDNA (solid line)and PNA-MB(dotted line). 
fluorescein should be turned off or decreased due to FRET. As illustrated in figure (Fig. 
2-27), upon duplex formation between the PNA-MB (II-7) and the cDNA                             
5`-TCGAAAAAGCT-`3 at 2 M scale the fluorophore is located in a distance from the 
4-(N,N-dimethylamino)azobenzene unit and as consequence the fluorescence intensity 
was increased by over 100 fold. 
  
 
2.5.6.1 Hybridization properties of dimethylaminoazobenzene-PNA 
sequence 
To evaluate the influence of 4-(N,N-dimethylamino)azobenzene moiety in the stability of 
the duplex formed between the azo-based PNA oligomer (II-6) and the complementary 
counterpart sequence “5`-TCGAAAAAGCT-3`”. The hybridization properties were 
studied by temperature dependent UV absorbance in 2:1 ratio at (6 M PNA: 3 M 
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cDNA) was evaluated near physiological ionic conditions (100 mM NaCl, 10 mM 
Na2HPO4, 0.1 mM EDTA at pH 7.0). It was found that incorporation of 4-N,N-dimethyl- 
aminoazobenzene moiety into PNA oligomer resulted in an increase of melting 
temperature ΔTm (+11 °C, with DNA) comparing to a control PNA oligomer. This 
increase in stability is may ascribed to the presence of hydrophobic azobenzene moiety at 
the end of the triplex structure that expected to stack well and therefore preventing end 
fraying.  
 
cDNA: 5`-TCGAAAAAGCT-3` 
 Tm C Δ Tm 
II-6, CTTTTTCX 52 +11 
Control PNA, CTTTTTC 41 --------------- 
 
Table ‎2-1: Melting Temperature 
 
 
Figure ‎2-28: Schematic representation for formation of triplex PNA2:DNA   
                       stabilized by azobenzene units. 
2.6 Conclusion 
We have described the synthesis of an Fmoc-PNA monomer possessing an integral          
4-(N,N-dimethylamino)azobenzene moiety as a nucleobase surrogate. This PNA 
monomer showed the ability to undergo a light-driven configurational change which 
might be beneficial for photoregulation of duplex stability between the PNA and 
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complementary nucleic acid. The azo-based PNA monomer also showed the ability to 
quench the fluorescence of fluorescein and pyrene and would be compatible with the 
same panel of dyes for which DABCYL is an effective quencher. The azo-based PNA 
monomer was successfully incorporated into oligomer using standard Fmoc-based 
oligomerization in a molecular beacon design with fluorescein as the optical label. As a 
result of hybridization of the azo-based PNA-MB to its complementary DNA, an increase 
of the fluorescence signal by 100 fold was observed. 
2.7 Experimental 
tert-Butyl-N-[2(-((9H-fluoren-9-yl)methoxy)carbonyl]amino)ethyl]amino]acetate 
HCl salt II-2 
To a stirred solution of ethylenediamine (20 mL, 0.3 mol) in 
CH2Cl2 (150 mL) at 0 C, tert-butyl bromoacetate (4 mL, 
0.03 mol) in CH2Cl2 (20 mL) was added with slowly 
addition over 5 h. The mixture was allowed to warm to r.t. and was stirred for 16 h. The 
mixture was washed with water (3 x 200 mL) and the combined organic solvent was 
collected, dried over Na2SO4 and filtered. A sample (1 mL) of the organic was evaporated 
and was dried to give product II-2 as oil: 
1
H NMR (CDC13) :  3.29 (s, 2 H), 2.77 (t, J = 
7.0 Hz, 2H), 2.65 (t, J = 7.0 Hz, 2H), 1.51 (s, 3H), 1.45 (s, 9H). To the filtered solution 
(4.35 g, 0.025 mol) DIEA (10.6 mL, 0.075 mol) was added followed by dropwise 
addition of FmocOSu (8.43 g,  0.025 mol) in CH2Cl2 (25 mL) over 5 hr and the mixture 
was stirred for 12 h. The mixture was washed with water (3 x 200 mL) and was dried 
over Na2SO4 and filtered then was concentrated under reduced pressure to (50 mL). A 
solution of saturated HCl/diethylether (8 mL) was added to the reaction mixture till the 
solution turned turbid, cooled at 0 C for 3 h and the resulted white solid was collected, 
dried to give the hydrochloride salt of the backbone (6.5 g, 60 %). 
1
H NMR (DMSO-d6) 
for II-2 : 9.27 (s, 2 H), 7.88 (d, J = 7.4 Hz, 2H), 7.68 (d, J = 7.4 Hz, 2H), 7.56 (t, J = 5.8 
Hz, 1H), 7.41 (t, J = 7.3 Hz, 2H), 7.32 (t, J = 7.3 Hz, 2H), 4.33 (d, J = 6.8 Hz, 2H), 4.22 
(t, J = 6.6 Hz, 1H), 3.86 (s, 2H), 3.32 (m, 2H), 2.98 (t, J = 6 Hz, 2H), 1.44 (s, 9 H). 
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4-[4-(N,N-Dimethylamino)phenyl]diazenyl]phenylacetic acid II-3. 
To an ice-cooled stirred solution of 4-aminophenylacetic acid (1.0 g, 6.62 
mmol) in 1 M HCl (30 mL), a cold solution of sodium nitrite (0.685 g, 
9.93 mmol) in H2O (3 mL) was added dropwise. The mixture was stirred 
for 30 min and the resultant solution of diazonium salt was transferred to 
dropping funnel then was added to a solution of N,N-dimethylaniline       
(1 mL, 7.94 mmol) in a mixture of glacial acetic acid and water (30 mL, 2:1, v/v). The 
mixture was stirred for 3 h. A brown solid precipitated after the pH was adjusted to 8 by 
use of an aqueous solution of 2 M sodium acetate. The solid was collected by filtration 
and was washed sequentially with cold water and ether and then dried to give product II-
3 in pure form (1.49 g, 80%), 
1
HNMR (400 MHz,CDCl3)  : 7.78 (d, J = 8.9Hz, 2H), 
7.72 (d, J = 8.2Hz,  2H), 7.40 (d, J = 8.2 Hz, 2H), 6.76 (d, J = 8.6 Hz, 2H), 3.7 (s, 2H), 
3.07 (s, 6H); 
13
C NMR (100 MHz,CDCl3)  : 177.1, 152.3, 143.6, 134.4, 129.8, 124.9, 
122.4, 111.5, 40.8, 40.3. HRMS (EI): calcd. For C16H17N3O2 [M
+
] 283.1321, found 
283.1323.  
 
tert-Butyl-2-[N -(2-((9H-fluoren-9-yl)methoxy)carbonylamino)ethyl]-2-[4-((4-(N,N-
dimethylamino)phenyl)diazenyl)phenyl)acetamido] acetate II-4.  
  
To a solution of II-3 (0.5 g, 1.76 mmol) in dry DMF (7 mL), DCC 
(0.366 g, 1.76 mmol) and HOBt (0.238 g, 1.76 mmol) was added. 
The reaction mixture was degased for 15 min and then was stirred 
for 1 h followed by the dropwise addition of a solution of the 
Fmoc-backbone ester, tert-butyl 2-(2-(((9H-fluoren-9-yl)methoxy) 
carbonylamino)ethylamino)acetate, (0.635 g, 1.6 mmol) in (5 mL) 
of dichloromethane. The mixture was stirred at r.t. for 36 h. The formed DCU was 
filtered; the filtrate was poured into ice-water with stirring which produced a brown 
precipitate. The solids were collected by filtration and then subjected to column 
chromatography using hexane/CH2Cl2 (70:30 v/v) as the eluent to afford II-3 (0.852 g, 
73%). Compound II-3 exists in solution as a pair of slowly exchanging rotamers; signals 
attributed to major (ma.) and minor (mi.) rotomers are designated: 
1
HNMR ( 400 MHz, 
CDCl3)  : 7.82 (d, J = 8.2 Hz, 2H), 7.79-7.74 (m, 4H), 7.58 (d, J = 7.4 Hz, 2H), 7.38-
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7.27 (m, 6H), 6.74 (d,  J = 8.2 Hz, 2H), 4.38 (d, J = 7.1 Hz, 2H ), 4.22 (m, 1H), 3.95 (s, 
mi., 0.6H), 3.91 (s, ma., 1.4H), 3.75 (s, ma., 1.3H), 3.67 ( s, mi., 0.7H), 3.58-3.48 (m, 
2H), 3.39-3.31 (m, 2H), 3.07 (s, 6H), 1.48 (s, 9H); 
13
C NMR (100 MHz,CDCl3)  : 156.5, 
152.4, 143.7, 141.2, 129.5, 127.6, 127.1, 125.0, 119.9, 112.6, 83.1, 82.3, 49.9, 47.1, 40.8, 
28.0. HRMS (ESI): calcd. For C19H44N5O5 [MH
+
] 662.3342, found 662.3328.  
 
2-(N-(2-(((9H-fluoren-9-yl)methoxy)carbonylamino)ethyl)-2-(4-((4’-N,N-dimethyl 
amino)-phenyl)diazenyl)phenyl)acetamido)acetic acid II-5. 
To an ice-cooled suspension of compound II-4 (0.5 g, 0.75 mmol) 
in dichloromethane (2 mL), TFA (2 mL) was slowly added and the 
reaction mixture was stirred for 1 hr in ice bath and for 3 h at r.t. 
The mixture was evaporated in vacuo to dryness and the remaining 
residue was coevaporated with dichloromethane (3 x 10 mL), was 
dissolved in dichloromethane (2 mL) and precipitated with the 
addition of diethyl ether (30 mL). The mixture was cooled to 0 C for 12 h, filtered, 
washed with cold ether and dried to give the title compound as red solid (0.416 g, 91 %). 
1
H NMR (400 MHz, DMSO)  : 8.11 (s, 1H), 7.89 (d, J = 7.4 Hz, 2H), 7.77 (d, J = 8.6 
Hz, 2H), 7.69-7.66 (m, 4H), 7.40-7.30 (m, 6H),  6.83 (d, J = 8.6 Hz, 2H), 4.31 (m, 1H), 
4.20 (d, J = 6.6 Hz, 2H), 3.85 (s, ma., 0.5H), 375 (s, mi., 1.5H), 3.63 (s, 2H), 3.40 (m, 
2H), 3.19 (m, 2H), 3.05 (s, 6H); 
13
C NMR( 100 MHz, DCM-d2)  : 161.1, 157.4, 144.4, 
141.7, 136.5, 131.1, 128.2, 127.6, 125.6, 120.4, 119.9, 115.8, 76.3, 67.5, 47.6, 42.1, 40.  
HRMS (ESI): calcd. For C35H36N5O5 [MH]
+
 606.2716, found 606.2739 
PNA Oligomer and PNA-MB synthesis 
PNA 8-mer was synthesized on a 5 mol scale using the standard FastMoc module on an 
Applied Biosystems 433A synthesizer using Nova SynTGR (Rink amide) resin. After the 
PNA synthesis was completed with uncapped N-terminus, the resin (40 mg,  ~ 2 mol) 
was transferred to a reaction vessel and was washed and drained with dry CH2Cl2 and 
DMF several times, DMF (1mL), FITC (6 equiv.) and DIEA (10 equiv.) were added and 
the reaction mixture was shaken in the dark for 6 h. The resin was washed with CH2Cl2 
and DMF, completion of FITC coupling was confirmed by Kaiser test. 
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Cleavage of the PNA-MB from the resin 
The PNA was cleaved from the resin with of TFA (1mL) for 90 min and the reaction 
mixture was filtered, the filtrate was evaporated with nitrogen stream and was treated 
with cold anhydrous diethyl ether (1 mL) to precipitate the crude PNA. The crude PNAs 
were dissolved in 0.05% TFA-H2O (300 L), filtered, and purified by RP-HPLC using a 
250 mm x 4.6 mm, C18-bonded phase, 100 pore, 5 μm particle size column. Column was 
eluted at a flow rate of 1mL/ min
 
with the solvent system:  A) TFA (0.05%, v/v) in H2o 
and B) TFA (0.05%, v/v) in CH3CN with a binary gradient elution  0-5 min, 100% A; 5-
20 min, 100% to 60% A; 20-30 min, 60% to 40% A; 30-40 min, 40% to 0%  and were 
characterized by MALDI-TOF mass spectrometry, for II-6 found 2345.0468 [MH
+
]
 
, 
(2345.0335. calcd. for C101H136N38O29) and for II-7 found 2735.1440 [MH
+
]
 
, 
(2735.0772. calcd. for C122 H148 N39O34S. 
PNA stock solutions were prepared in deionized water and stored at -4°C. Concentrations 
of PNA oligomer were determined by measuring UV absorbance at 260 nm at 80 °C and 
the extinction coefficients were calculated by summing the values for the individual 
nucleobases, FITC (70000 M
-1
 cm
-1
),  and 4-(N,N-dimethylamino)azobenzene (32600   
M
-1
 cm
-1
). 
Photoisomerization study 
UV-Vis spectra were measured with a Varian Cary 300 Bio spectrophotometer. A 
solution of II-5 (2.06 × 10
-5
 M) in dichloromethane with 7.08 × 10
-2
 M of NEt3 was 
irradiated in a quartz cuvette at room temperature using a UVGL-58 hand held lamp (6 
watt, 366 nm) at a distance of approximately 4 cm. At given time points, a UV-visible 
spectrum was collected. The time course for spontaneous reversion was monitored at the 
wavelength of maximum change (411 nm). 
 
Fluorescence studies 
Fluorescence measurements were carried out on a Photon Technologies International 
Quanta Master 7/2005 spectrophotometer, excited at 488 nm and detected at 490-650nm. 
First, the fluorescence intensity was measure for a sample of 2 M of azo-based PNA-
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MB under ionic conditions (100 mM NaCl, 10 mM Na2HP04, 0.1 mM EDTA at pH 7.0) 
in 1 cm-qartz cuvette. The cDNA at 2 M concentration was added to the PNA-MB and 
incubated for 1 hr to form duplex with the PNA-MB (II-7) and followed by measuring 
the fluorescence intensity of fluorescien.  
Hybridization studies:  
Hybridization and UV melting experiments were carried on a Varian Cary III under the 
same buffer condition used previously, melting experiments were performed at 6 μM 
concentration for PNA-MB and 3 μM concentration for cDNA (2:1) ratio for triplex 
formation. Sample was heated to 95 °C for 2-3 min, cooled to room temperature over 45 
min. Denaturation was performed from 10 °C  to 85 °C at a scan rate of 0.5 °C/min. The 
Tm values are an average of three measurements and are rounded to the nearest 0.5 °C. 
The error in Tm values was ± 0.5 °C. Tm values were estimated for cooperative transitions 
by the first derivative method. ΔTm values are the difference between the melting 
temperature Tm of azo-based PNA oligomer (II-6) and the PNA control sequence 
[without 4-(N,N-dimethylamino)azobenzene monomer] 
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Chapter 3  
3 Synthesis and Photophysical Studies of Novel Quencher for 
PNA  
3.1 Introduction 
 To the best of our knowledge introduction of azobenzene derivatives into peptide nucleic 
acid was accomplished by inclusion of azobenzene residues as a replacement for the 
nucleobases. (Fig. 3.1).
1a-c
 In this chapter, we are interested in the synthesis of a novel 
azo-based PNA monomer that possess the azophenyl moiety which provides the 
photoswitching property in addition to its potential quenching effect with maintaining 
hydrogen bonding ability with the complementary nucleobase. To achieve this goal, 
uracil nucleobase has been chosen as starting point, by simple chemical modifications to 
introduce phenylazo moiety at C-5 position which is characterized by it does not interfere 
with the hydrogen bonding sites of uracil. 
 
Figure ‎3-1: Examples of azo-based PNA monomers. 
We are interested in the synthesis of 4-(N,N-dimethylamino)phenylazouracil analog 
(DMA) because it structurally mimics the universal 4-(N,N-dimethylamino)azobenzene-
4-benzoic acid quencher (DABCYL) that is widely used in Fluorescence Resonance 
Energy Transfer (FRET) applications as shown in (Fig. 3-2), and this may leads to a new 
PNA-quencher. 
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Figure ‎3-2: Similarity in structure between DABCYL and the modified uracil 
3.2 Results and discussion 
The synthesis of azo-based PNA monomer is outlined in (Scheme 3-1). Starting with 
diazotization of commercially available 5-aminouracil affords the corresponding 
diazonium salt solution followed by coupling with N,N-dimethyl aniline following the 
reported procedure
2
 to give 4-(N,N-dimethylamino)phenylazouracil III-1 in 80% yield. 
Alkylation of compound III-1 with  t-butyl bromoacetate under basic conditions at N-1 to 
afford the corresponding ester III-2 which underwent removal of  t-butyl group by TFA 
treatment to obtain the acid derivative III-3 in 90% yield. Carbodiimide mediated 
condensation of III-3 with N-[2-(Fmoc)aminoethyl]glycine-t-butyl ester gave the desired 
monomer ester III-4. Finally, removal of t-butyl group was carried out by acidolysis 
using TFA to give the azo-based PNA monomer III-5 in 89% yield. 
 
Scheme ‎3-1: Synthesis of 4-(N,N-dimethylamino)phenylazouracil PNA monomer. 
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Azobenzenes are known to have two configurational isomers which are trans and cis. The 
trans isomer is the most thermally stable due to lack of steric clash that was found in cis 
isomer. Similarly, 4-(N,N-dimethylamino)phenylazouracil derivatives are expected to 
exist in trans form. To confirm this assumption, a crystal structure of tert-butyl-4-(N,N-
dimethylamino)phenylazo-5-uracil-1-yl acetate III-2 was obtained that confirmed the 
trans configuration as shown in (Fig. 3-3). Selected bond distances (Å) and angles (°), 
with estimated standard deviations in parentheses is shown in Table 3-1. 
 
Figure ‎3-3: The X-ray crystal structure of III-2 showing the phenylazouracil unit is   
                       existing in trans-configuration. 
 
 Bond lengths Å]  Angles  [°] 
N3-N2  1.268(4) N2-N3-C32 110.6(3) 
N3-C32 1.424(4) C33-C32-N3  122.6(3) 
N2-C8  1.408(4) N3 C32 C31  117.6(3) 
N4-C11  1.454(4) C35-N4-C11  117.5(3) 
N5-C35  1.364(4) C35-N5-C31  127.5(3) 
N4-C11  1.454(4) C33-N4-C11 120.4(3) 
Table ‎3-1: Selected bond distances (Å) and angles (°) for III-2 
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3.2.1     Photoisomerization of azo-based uracil derivative and solvent 
effect on its absorption spectrum 
Similarly to azobenzene, 4-(N,N-dimethylamino)phenylazouracil derivatives are expected 
to undergo a transformation from the thermally stable trans isomer to the cis form by 
irradiation with UV light, while the reverse transformation cis-to-trans can be achieved 
either by illumination with visible light or thermally.
3a,b
 
 
Figure ‎3-4: Photoisomerization of 4-(N,N-dimethylamino)phenylazouracil 
derivatives. 
4-(N,N-Dimethylamino)phenylazouracil acetic acid III-3 has been chosen as a model to 
investigate its photoisomerization ability due to it showed good solubility in water and 
various organic solvents. The maximum absorption band and molar extinction coefficient 
of III-3 under different solvent is reported in (Table 1). 
Solvent H2O EtOH CH3CN MeOH Acetone DCM 
max/nm 465 436 439 441 437 459 
(L/Mol.cm-1) 14480 32474  24855 27087 28982 ----- 
Table ‎3-2: Maximum absorption wavelength and molar extinction coefficient of  
                   compound III-3 in various solvents. 
As shown in (Table 3-2), compound III-3 showed positive solvatochromic effect, in other 
words, the absorption maximum wavelength is increased with the increase of solvent 
polarity. As demonstrated in (Fig. 3-5), UV-Vis absorption spectrum of III-3 in 
acetonitrile exhibited a characteristic broad absorption band centered at 439 nm 
corresponding to -* transition of azophenyl moiety. Upon illumination with 366 nm 
light, compound III-3 underwent trans-to-cis isomerization accompanied with decrease 
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in the intensity of -* band at 439 nm which is derived mainly from the azo moiety. 
Recovery of trans isomer was achieved by thermal relaxation.  
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Figure ‎3-5: Absorption spectrum of III-3 in CH3CN at 3.78 M. The arrow indicates 
the direction of change in peak at 439 nm upon irradiation with 366 nm light. 
3.2.2 pH-Sensitivity of azo-based uracil 
Similar to the acid effect study that was carried out on the azobenzene PNA monomer 
(discusses in chapter 2), on the basis of structural similarity between 4-(N,N-dimethyl- 
amino)azobenzene and 4-(N,N-dimethylamino)phenylazouracil, we have investigated the 
effect of acids on compound III-3 using UV-Vis spectroscopy.  
 
Figure ‎3-6: Schematic representation of azonium and ammonium ions. 
As shown in (Fig. 3-6), there are two sites, dimethylamino- and azo groups, susceptible 
for protonation. Interestingly, upon addition aqueous solution of 3 mM HCl to compound 
III-3 in different solvents, in nonpolar solvents as benzene and toluene only azonium ion 
band (usually appears at > 500nm) was observed while with the increase of solvent 
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polarity both azonium and ammonium ions (usually appears at < 400)
4
 bands were 
observed (Fig. 3-7).  
 
Solvent DMSO H2O EtOH CH3CN MeOH Acetone DCM Toluene Benzene 
max/nm 
(Neutral) 
453 469 436 439 441 437 459 452 452 
max/nm 
(protonated) 
351 349 585/359 595 593/351 587 612 607 605 
Table ‎3-3: Effect of addition of 3 mM HCl on absorption maximum wavelength 
(max) of   III-3, max of  ammonium ion is shown in bold. 
 
 
 
Figure ‎3-7: Spectral change of III-3 at a) 10.5 M concentration in CH3COCH3 
b) 8 M concentration in CH3CN upon addition of 3 mM HCl. 
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As demonstrated in (Fig. 3-8), we monitored the effect of TFA on III-3 
spectroscopically. Upon addition of small aliquots of TFA in acetonitrile (0.005 M) to 
III-3 in acetonitrile, a noticeable decrease of the non-protonated -* absorption band 
centered at 439 nm was observed, similar to the effect of HCl, with appearance of a new 
absorption band at 595 nm for the protonated form with clear isosbestic point at 504 nm. 
Comparing  these results with that carried out in ethanol, nonprotonated form appeared at 
436 nm, while after protonation with ethanolic solution of TFA, two new absorption 
bands at 352 nm and 585 nm were observed. This phenomenon can be explained based 
on the fact that due to the presence of two sites dimethylamino- and azo groups which are 
amenable for protonation with the acid producing ammonium ion and azonium ion, 
respectively.  
 
 
 
 
 
 
 
 
 
 
Figure ‎3-8: Effect of TFA on III-3 at a) 10.5 M concentration in CH3CN at range 
(0-18M) (0-1.7 equivalent), b) at 6 M concentration in EtOH at range (0-14 M) 
(0-2.3 equivalent), arrow directions indicates the spectral change upon addition of 
TFA.  
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Interestingly, azo-nucleobase derivative III-3 displayed intriguing halochromism 
property. It was observed that treatment of III-3 in various solvents with halogenated 
acids, as trifluoroacetic acid, gave dramatically different colours. Halogenated solvents as 
chloroform or dichloromethane produced a deep blue colour. While under basic 
conditions the reversible change to deep yellow/orange was observed (Fig. 3-9 and 3-10). 
Surprisingly, mineral acids did not effect this colour change, nor was the colour change 
observed in oxygenated solvents (H2O, alcohols, Et2O, EtOAc, and THF).  The blue 
colour in halogenated solvents was not quenched by shaking against water either. These 
perplexing phenomena continue to be investigated which may lead to its use as a non-
aqueous pH indicator.  
 
Figure ‎3-9: Compound III-3 in a) various solvents: from left to right: dioxane, 
dichloromethane, chloroform, diethyl ether, methanol, ethanol and H2O. b) after 
addition of TFA., c) after basification. 
  
 
Figure ‎3-10: Compound III-3 in DCM with A) Trifluoroacetic acid, B: 
Dichloroacetic acid, c: fluorodichloroacetic acid, D: trichloroacetic acid, E:  AcOH.  
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To assess the quenching ability of the azo-based PNA monomer III-3, a preliminary 
study using similar protocol that has been used in chapter 2, two fluorophores: 
fluorescein and pyrene were used. As shown from the absorption spectra of III-3 in 
ethanol, it has absorption range 350-525 nm with maximum wavelength 436 nm which is 
expectedly overlap with emission spectra of fluorophores that used in the study.  A 
solution of fluorophores in ethanol was titrated with aliquots of compound III-3. As 
illustrated in (Fig. 3-11 and 3-12), upon addition of small portions of III-3 to the 
fluorophore, a subsequent fluorescent signal is quenched with the increase of III-3 
concentrations. 
 
 
 
 
Figure ‎3-11: Fluorescence changes of 8 M fluorescein upon addition of various 
amount of III-3 in EtOH at the range (0-0.1 M) with excitation wavelength 488 nm. 
 
 
 
 
 
 
Figure ‎3-12: Fluorescence spectra of 5 M concentration of pyrene in ethanol 
recorded upon addition of varied amount of III-3 in EtOH at the range (0-1 M) 
with excitation wavelength 330 nm. 
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3.2.3 Design and synthesis of dual peptide for quenching study 
We have designed and synthesized a FRET-peptide MB containing the azo-based PNA 
monomer. FRET peptides are peptides labeled with fluorescent dye (donor) at one 
terminal and a non fluorescent dye (acceptor) at the other terminal, due to presence of the 
donor and acceptor in close proximity no fluorescence emission is observed due to 
fluorescence energy transfer (FRET). FRET peptides are widely used mainly for 
detection of proteases and protein kinases activities.
5
 The choice of both donor and 
acceptor is very crucial to have a good FRET peptide. The donor should have high 
fluorescence quantum yield and the acceptor should have the ability to quench the 
emission of the donor. In other words, the emission spectrum of the donor must overlap 
with the excitation spectrum of the acceptor. As illustrated in (Fig 3-13), when the 
acceptor is close enough, excitation is transferred from the donor to the acceptor without 
emission of photons and as a result the fluorescence of the donor is quenched. By the 
effect of enzymatic degradation on a specific site of peptide sequence, the donor 
separates from the acceptor and subsequently the quenching effect is lost and leading to 
increase of the emission intensity of the donor.  
 
 
Figure ‎3-13: Schematic representation on the mechanism of FRET-Peptide. 
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The peptide sequence is determined based on the given protease; in this study we have 
used Cathepsin D (Cat D), lysosomal aspartyl endopeptidase. Cat D is known to cleave 
peptide bonds mainly between hydrophobic amino acids units.
6a,b, 
As shown in (Fig. 3-
14), we have designed a peptide sequence, contains core cleavage sequence (ILFFRL) 
based on literature report
7
 showed that Cat D was effectively cleaved the peptide bond 
between the two phenylalanine units. The synthesized PNA was labelled with fluorescein 
as optical tag at the N-terminal.  
 
Figure ‎3-14: Designed FRET Peptide having azo-based PNA monomer as quencher 
and FITC as fluorophore. 
The desired FRET peptide was synthesized by Fmoc mediated solid peptide phase 
strategy. After the completion of the sequence synthesis, fluorescein was introduced 
manually to the uncapped N terminal and completion of the fluorescein labelling was 
confirmed by Kaiser test. The peptide was cleaved from the resin by TFA and was 
purified by reversed phase high pressure liquid chromatography. To confirm the 
formation of the synthesized peptide by mass spectrometry, unfortunately, the expected 
mass for the desired dual labelled peptide cannot be observed. The mass spectrum has 
shown a peak at m/z 1478.8732. It was found that this mass peak is attributed to the 
peptide sequence ILFFRLA-XAK with no evidence of the presence of fluorescein 
moiety or the last amino acid glycine. By reviewing the literatures, a similar case was 
reported by Jullian and coworkers,
8
 they postulated that this type of degradation could 
occurred during the cleavage of the peptide from the resin by TFA through a cyclization 
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leading to the formation of a fluorescein thiohydanation with subsequent removal of the 
last amino acid following a mechanism similar to Edman degradation
9
 (Scheme 3-2).  
 
 
 
Scheme ‎3-2: Degradation mechanism of FITC labelled peptide by the effect of TFA. 
As illustrated in the mechanism, formation of five-membered ring is only possible when 
the last residue is -amino acid. Simply to avoid such degradation, this can be achieved 
by using resin that susceptible to non-acidic cleavage of the targeted peptide or by using 
longer spacer as -alanine or amino hexanoic acid.  
To circumvent the degradation of the peptide, we have modified the design of the peptide 
by replacing glycine residue with -alanine (Fig. 3-16) and the desired peptide sequence 
was built at the peptide synthesizer followed by coupling of fluorescien manually. The 
synthesis of the FRET-peptide was confirmed primarily from UV-Vis spectra as shown in 
(Fig. 3-15) absorption band at 465 nm attributed to 4-(N,N-dimethylamino) 
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phenylazouracil and  at 485 nm for fluorescein and by mass spectrometry a peak at m/z 
1938.0471[MH
+
] was observed for the desired dual peptide. 
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Figure ‎3-15: UV-Vis spectra of FRET-Peptide showed bands at 462 nm for DMAzo   
                      unit and at 485 nm for FITC. 
 
Figure ‎3-16: Schematic representation of the modified dual labelled peptide design. 
To assess the quenching ability of the azo-based modified uracil, the fluorescence of 
fluorescein in dual labeled peptide was measured at emission wavelength at 520 nm with 
excitation at 488 nm. The FRET-Peptide was subjected to Cat D digestion for 30 min and 
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the fluorescence intensity was measured again as shown in (Fig. 3-17), it was found that 
the emission intensity was increased by 3.5 fold due to cleavage of the peptide at the 
bond between F-F. The digested products were analyzed by MALDI-MS, there was no 
sign of undigested substrate peak at m/z 1938.0471 which indicates that the digestion had 
gone for completion and moreover a peak at m/z 1103.0483 was observed for the 
cleavage product attributed to sequence FRLAXAK as a result of cleavage between the 
F-F (Fig. 3-19). 
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Figure ‎3-17: Fluorescence emission spectrum of dual peptide with excitation at 488   
                         nm upon hydrolysis by Cat. D 
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Figure ‎3-18: Mass spectrum of FRET-peptide, Calc. 1938.9478, found 1938.0471                         
                      [MH
+
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Figure ‎3-19: Mass spectrum of FRET-peptide after digestion , Calc. 1103.6627, 
found 1103.0463 [MH
+
]
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3.3 Conclusion  
We have synthesized a novel modified azo-based uracil PNA monomer for the utility as a 
quencher for PNA-MB design. The synthesized monomer has shown the ability to 
quench fluorescien and pyrene emissions. In addition, it was incorporated into in dual 
peptide sequence that was used in the evaluation of the activity of Cathepsin D. The azo-
based PNA monomer may has potential application in photoregulation of hybridization 
due to it showed trans-to-cis photoisomerization upon illumination with UV-light (366 
nm) and trans isomer was recovered thermally. The synthesized PNA monomer has 
showed a characterized spectral change upon changing the pH, this may led to a new type 
of pH-indicator based on modified nucleobase. 
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3.4 Experimental  
5-Diazouracil
10
 
To a cold solution of 5-aminouracil (3.0 g, 23.62 mmol) in 
hydrochloric acid 1N (45 mL), a solution of 6.9 % NaNO2 (18 mL) 
was added dropwise over a period of 15 min. a pal yellow solid was 
precipitated. The reaction mixture was stirred for further 30 min for 
complete precipitation. Solid was collected by filtration, wash with iced water and was 
dried under vacuum to give (3.12 g, 84%) and used for the next step without further 
purification.  
5-[4(N,N-Dimethylamino)phenyl)diazenyl]-(1H,3H)-pyrimidine-2,4-dione III-1. 
A suspension of 5-diazouracil (2.0 g, 12.8 mmol) in anhydrous 
acetonitrile (160 mL) was purged with N2 for 10 min, 
borontrifluoride etherate (1.64 mL, 12.8 mmol) and  N-N-
dimethylaniline (1.53 mL, 12.8 mmol) were added to the mixture 
and was stirred for 2 h. The separated solid was filtered and refluxed in EtOH (150 mL) 
for 1 h. The solid was collected and dried to afford (2.58 g, 80%) of  III-1. 
1
H NMR (400 
MHz, DMSO-d6)  : 11.42 (s, 1H), 11.28 (s, 1H), 7.66  (s, 1H), 7.61 (d, J = 8.9 Hz, 2H),  
6.79 (d, J = 8.7 Hz, 2H),  3.01 (s, 6H);  
13
C NMR (100 MHz, DMSO-d6)  : 161.8, 152.7, 
151.3, 143.5, 130.7, 129.5, 124.9, 112.2, 47.6. HRMS (EI): calcd. for C12 H13 N5O2 [M
+
] 
259.1069 found 259.1062 
tert-Butyl 2-(5-[(4(N,N-dimethylamino)phenyl)diazenyl)]-2,4-dioxo-3,4-dihydro 
pyrimidin-1(2H)-yl)acetate III-2. 
To a solution of III-1 (1.0 g, 3.86 mmol) in dry DMF (8 mL), 
tert-butyl-2-bromoacetate (0.93 g, 3.86 mmol) and anhydrous 
K2CO3 (0.54 g, 3.9 mmol) were added. The reaction was stirred 
for 24 h under N2, the solid was filtered through celite, and the 
solvent was removed under reduced pressure. The residue was 
dissolved in dichloromethane (100 mL) and washed with aqueous saturated Na2CO3 (2 x 
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50 mL), brine (50 mL) and dried over Na2SO4. The combined organic solvent was 
concentrated under pressure to obtain a yellow oil which was purified via flash 
chromatography using  ethyl acetate/ hexane as eluting solvents (7: 3, v/v)  to yield III-2 
as a yellow solid (0.98 g, 74%). 
1
H NMR (400 MHz, DMSO-d6)  : 11.8 (s, 1H), 8.06 (s, 
1H), 7.65 (d, J = 8.4 Hz, 2H),  6.79 (d, J = 8.4 Hz, 2H), 4.52 (s, 2H), 3.02 (s, 6H), 1.41 (s, 
9H); 
13
C NMR (100 MHz, DMSO-d6)  : 167.7, 161.8, 152.8, 150.9, 143.5, 134.6, 129.6, 
125.3 112.2, 82.6, 50.51, 28.3. HRMS (EI): calcd. for C18 H23 N5O4 [M
+
] 373.1750 found 
373.1732. 
tert-Butyl 2-(5-[(4(N,N-dimethylamino)phenyl)diazenyl)]-2,4-dioxo-3,4-dihydro 
pyrimidin-1(2H)-yl) acetic acid III-3. 
To a cold solution of III-2 (0.90 g, 2.41 mmol) in dry 
dichloromethane (3 mL), TFA (3 mL) was added dropwise, 
the reaction mixture was stirred for 4 h at r.t. under N2.          
A cold diethylether (15 mL) was added and the mixture kept 
overnight at 4 C. The resultant solid was collected by 
filteraion, washed with cold doethylether and dried to give III-3 (0.69 g, 90%) as 
yellowish brown solid. 
1
H NMR(400 MHz, DMSO-d6)  : 13.22 (s, br, 1H), 11.78 (s, 
1H), 8.07 (s, 1H) 7.65 (d,  J = 8.9 Hz, 2H), 6.81 (d, J = 8.9 Hz, 2H), 4.55 (s, 2H), 3.03 (s, 
6H); 
13
C NMR (100 MHz, DMSO-d6)  : 170.1, 161.4, 152.8, 150.9, 143.5, 134.7, 129.6, 
125.0, 112.2, 49.8. HRMS (EI): calcd. for C14 H15 N5O4 [M]
+
 317.1124 found 317.1121. 
tert-Butyl-2-(N-(2-(((9H-fluoren-9-yl)methoxy)carbonylamino)ethyl)-2-(5-[(4-N,N-
dimethylamino)phenyl)diazenyl)]-2,4-dioxo-3,4-dihydropyrimid-in-1(2H)-
yl)acetamido)acetate III-4.    
To a cold  solution of compound III-3 ( 0.50g, 1.57 mmol) in dry 
DMF (7 mL), DCC (0.32 g,  1.57 mmol) and HOBt (0.21 g, 1.57 
mmol) were added. The reaction purged with N2 for 15 min then 
was stirred for 1h under ambient atmosphere, followed by 
dropwise addition of asolution of N-[2-(Fmoc)aminoethyl] 
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glycine-t-butyl ester  (0.63 g, 1.57 mmol) in dichloromethane (5 mL). The reaction was 
stirred under N2 for 24 h, filtered through celite to remove the formed DCU and the 
solvent was removed under reduced pressure. The residue was dissolved in  
dichloromethane (50 mL), washed with aqueous 5% NaHCO3 (50 mL) (2 x 50 mL), and 
brine (50 mL) and dried over Na2SO4. The organic solvents were removed under pressure 
and the residue was supjected to flash chomatography using ethylacetate/hexane (7:3, 
v/v) as the eluting solvents. The combined fractions was evaporated to give III-4 as 
yellow solid (0.72 g, 65% ). Compound III-4 exists in solution as a pair of slowly 
exchanging rotamers; signals attributed to major (ma.) and minor (mi.) rotomers are 
designated : 
1
H NMR (400MHz, DMSO-d6)  : 11.76 (s, 1H), 8.09 (s, 1H) 7.89 (d, J = 
7.5, 2H), 7.69-7.60 (m, 4H), 7.42-7.32 (m, 4H),  6.78 (d, J = 7.6  Hz, 2H), 4.86 (s, ma., 
1.2H), 4.67 (s, mi., 0.8H), 4.34-4.18 (m, 4H), 3.95 (s, 1H), 3.70 (s, 1H), 3.42-3.39 (m, 
2H), 3.27-3.26 (m, 2H), 3.01 (s, 6H), 1.46 (s, mi., 3H), 1.36 (s, ma., 6H); 
13
C NMR (100 
MHz, DMSO-d6)  : 161.1, 156.2, 155.6, 150.7, 143.9, 142.8, 140.7, 130.1, 128.9, 127.6, 
126.8, 125.1, 124.3, 120.1, 111.5, 77.6, 72.47, 65.3, 46.7, 36.9, 28.2.  HRMS (ESI-TOF): 
calcd for C37 H42 N7O7 [MH
+
] 696.3146 found 696.3107. 
2-(N-(2-(((9H-fluoren-9-yl)methoxy)carbonylamino)ethyl)-2-(5-[(4-N,N-dimethyl 
amino)phenyl)diazenyl]-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)acetamido)acetic 
acid III-5. 
To a cold solution of ester III-4 (0.35 g, 0.5 mmol) in 
dichloromethane (2 mL), TFA (2 mL) was added over 10 min. The 
reaction mixture was stirred under N2 for 6 h. The solvent was 
evaporated in vacuo. The residue was coevaporated with 
dichloromethane (4 x 10 mL). The residue was dissolved in 
dichloromethane (2 mL), diethylether (5 mL) was added, and the mixture was stored at 4 
C overnight, the resulting solid was filtered and dried to afford III-5 as yellow solid 
(0.29 g, 89%). Compound III-5 exists in solution as a pair of slowly exchanging 
rotamers; signals attributed to major (ma.) and minor (mi.) rotomers are designated : 
1
H 
NMR (400MHz, DMSO-d6) 11.67 (s, 1H), 8.07 (s, 1H) 7.84 (s, ma, 0.6 H), 7.87 (d, J = 
7.4 Hz, 2H), 7.83 (s, mi., 0.4 H) 7.65-7.50 (m, J = 7.4 Hz, 4H), 7.38-7.20 (m, J = 7.6 Hz, 
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2H ), 7.30 (m, J = 7.6 Hz, 2H), 6.76-6.64 (m,  J = 7.6 Hz, 2H), 4.84 (s, 1H), 4.65 (d, J = 
7.6 Hz, 1H),  4.31 (d, J = 7.8 Hz, 2H), 4.18-4.11 (m, J = 7.6 Hz, 1H), 3.93 (s, 1H), 3.86 
(s, 1H), 3.39 (t, J = 7.8  Hz, 1H), 3.25 (t, J = 7.8  Hz, 1H), 3.01 (s, 6H). HRMS (ESI-
TOF): calcd for C33H34N7O7 [MH
+
] 640.2520 found  640.2514. 
Fluorescnece-quenching studies 
Fluorescence measurements were carried out on a Photon Technologies International 
Quanta Master 7/2005 spectrophotometer. All the fluorescence titraions are carried out in 
ethanol containig 5 M concentarions for pyrene and 8 M for fluorescein. 1 ml of 
ethnolic solution of fluorophore was placed in 1cm-fluorescene cell and a small portions 
(10 L) of III-3 at 5 M concentartion was added. The emmission spectum was recorded 
with excitation wavelength set at 488 nm and monotiring emission signal of fluorescein 
at 520 nm and of pyrene at ( 337, 395 and 418 nm). 
Crystallography 
Crystals of III-2 were grown from a concentrated dichloromethane solution by slow 
diffusion of hexane.  An orange plate was mounted on a glass fiber.  Data were collected 
at low temperature (-123 C) on a Nonius Kappa-CCD area detector diffractometer with 
COLLECT (Nonius B.V., 1997-2002). The unit cell parameters were calculated and 
refined from the full data set. Crystal cell refinement and data reduction were carried out 
using HKL2000 DENZO-SMN (Otwinowski & Minor, 1997). The absorption correction 
was applied using HKL2000 DENZO-SMN (SCALEPACK). The crystal data and 
refinement parameters for III-2 CH2Cl2 are listed in (Table 3-3).  
The SHELXTL/PC V6.14 for Windows NT (Sheldrick, G.M., 2001) suite of programs 
was used to solve the structure by direct methods. Subsequent difference Fourier 
syntheses allowed the remaining atoms to be located. Distinct molecules were formed.  
The molecule was very well ordered.  The solvent was located on a symmetry element 
and was modeled as an anisotropic C and Cl atom. All of the non-hydrogen atoms were 
refined with anisotropic thermal parameters. The hydrogen atom positions were 
calculated geometrically and were included as riding on their respective carbon atoms. 
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Crystal III-2 
Empirical formula  C19 H25 Cl2 N5 O4 
Formula weight  458.34 
Crystal system Monoclinic 
Crystal dimensions  0.20 x 0.18 x 0.15(mm
3
) 
Space group P 21/n 
Z 4 
Unit cell dimensions a =13.151(3) Å 
b =10.740(2) Å 
c =17.188(3) Å 
α = 90° 
β = 112.31(3)° 
γ = 90° 
Collection ranges -16<=h<=16; -13<=k<=13; -20<=l<=20 
Density(calculated) 1.356 Mg/m
3
 
Temperature  150(2) K 
Volume  2245.7(8) Å
3
 
Denisty (calculated)  1.355(Mg m
-3
) 
Radiation Mo Kα (λ = 0.71073 Å) 
Absorption coeff.  0.324 mm-1 
Absorption correction Multi-Scan 
F(000) 960 
Theta range for data collection 1.68to 27.12° 
Observed reflections 17227 
Data/restraints/parameters 4945/1/271 
Final R indices (l > 2σ(l)) R1 = 0.1145, wR2 = 0.2453 
R indices (all data) R1 = 0.0769, wR2 = 0.2124 
Goodness-of-fit on F
2
 1.036 
Table ‎3-4:  X-ray crystallographic structural parameters for compound III-2. 
Synthesis of dual labeled peptide: 
Synthesis of the peptide sequence was obtained using preloaded NovaSyn TGR resin 
with loading 0.0655 mmol/g on 5 mol scale using the standard FastMoc module on an 
Applied Biosystems 433A synthesizer. After synthesis completion, the last Fmoc 
protecting group was removed and fluorescein isothiocyanate (FITC) coupling to the N-
terminal of the last amino acid was performed manually.  
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Peptide labeling with FITC  
After completion of the peptide synthesis with uncapped N-terminal, 30 mg (~ 2 mol) of 
the resin was transferred to a peptide vessel and resin was washed with dry CH2Cl2 (3 
mL), and drained followed by DMF wash (3 mL), and drained. A solution of FITC 
(3equiv.) and DIEA (6 equiv) in of dry DMF (1 mL) was added to the resin. Vessel was 
shaken for 12 h in the dark at r.t. Completion of FITC coupling was confirmed by Kiesr 
test. The dual-labeled peptide sequence was cleaved off and was purified by RP-
HPLC.The solvent was drained, the resin was washed with dry CH2Cl2 (3 mL) and DMF 
(3 mL) and dried. 
Cleavage of the peptide from resin 
To 20 mg (~ 1.3 mol) of the resin-bound peptide, in a glass vial, of TFA (1 mL) was 
added and the mixture was purged with nitrogen and was shaken for 1.5 h. The mixture 
was filtered and the resin was rinsed with of TFA (0.5 mL). The combined TFA was 
evaporated with a stream of nitrogen to obtain a sticky residue to the glass vial. By the 
addition of cold ether (3 mL), an orange precipitate was formed and was collected 
through decantation of the ether. The solid was dissolved in 0.05% TFA-H2O (300L), 
filtered, and purified by RP-HPLC using a 250 mm x 4.6 mm, C18-bonded phase, 100 
pore, 5 μm particle size column. Column was eluted at a flow rate of 1.1 mL/min with the 
solvent system:  A) TFA (0.05%, v/v) in H2O and B) TFA (0.05%, v/v) in CH3CN with a 
binary gradient elution 0-5 min, 100% A; 5-20 min, 100% to 60% A; 20-40 min, 60% to 
0%. The collected fractions was lyophilized and was dried to give yellowish-white pellet 
which was dissolved in mili-Q water (100 L) and was stored at -4 C. 
Hydrolysis of FRET-peptide by Cat D.  
The emission spectrum was measured for a sample of the dual peptide (0.1 mol) in       
20 mM citrate-phosphate buffer at a pH 4.5 followed by addition of Cathepsin D (0.01 
units, ~0.7 g) from bovin spleen, sigma, for digestion. The reaction mixture was 
incubated at 40 C for 30 min then was left to cool to room temperature followed by 
measuring the emmission of fluorescien signal after digestion.  
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Chapter 4  
4 Synthesis and Photophysical Studies of Novel photochromic 
Phosphoramidite for DNA and RNA 
4.1 Introduction  
Hybridization of nucleic acids is considered the cornerstone for many biomedical 
applications as antigene and antisense. Recently, much effort has been devoted to 
controlling DNA functions through external stimuli as light, pH, electric field and heat. 
Light is preferred over all other external stimuli due to reasons such as light is efficient, 
clean and does not produce any contaminants to the biological system. Light is a 
powerful tool to control several bioactive species such as protein, peptides and nucleic 
acids. 
Photoregulation of nucleic acids is based on covalent attachment of a photoresponsive 
molecule to the single-stranded DNA. This process can be achieved by i) introduction of 
photolabile protecting groups called caging groups. ortho-Nitrobenzyl group  (ONB) is 
an example for caging groups that have been widely used in photoregulation of 
oligonucleotide and peptides.
1
 Recently the ONB group has been used for photocontrol of 
several biological processes such as gene expression, ribozyme cleavage and RNA 
polymerase activity.
2a-c
 In these processes, the ONB group is able to cage substrates and 
then release them upon photoirradiation. ONB groups are removed under mild irradiation 
with long-wavelength UV radiation (>345 nm) without damaging the biological system. 
In this strategy, regulation occurs only once and in one direction. Alternatively, ii) a 
photoswichable molecule as azobenzene may be used.
3a,b  
Photoisomerization of azobenzene has been used to photo-control several molecular 
processes.  Azobenzene residues were introduced to oligonucleotides via two approaches: 
as a side chain on the oligonucleotide phosphate backbone;
4a-c
 and/or as a linker between 
two oligonucelotide segments in the main chain of an oligonucleotide.
5a,b  
Inocorporation 
of azobenzene as a side chain of the oligonucleotide backbone induces trans-to-cis 
isomerization and therfore exerts notable affects on the physicochemical properties and 
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on the duplex formation abilities of oligonucleotides. Although, the utility of azobenzene 
as a linker has been demonstrated an efficient trans-to-cis photoisomerization, no 
successful application has yet been reported.  
 
 
Figure ‎4-1: Modified oligonucleotides carrying azobenzene a) in the side chain, b) as     
                     linker. 
Introduction of several azobenzene residues to oligonucleotides led to an increase in 
melting temperature difference ΔTm corresponding to the photo-induced isomerization. 
For example, incorporation of one azobenzene residue into a short 8-mer oligonucleotide 
forming a duplex, upon trans-to-cis photoisomerization caused a decrease in ΔTm by 
14.3 C, while when two azobenzene residues were incorporated, a decrease in ΔTm by 
21.5C was observed. Incorporation of large numbers of azobenzene residues to duplex 
structure resulted in deviation of the duplex structure far from the B-form and thusly lost 
its ability to interact with proteins.
6
 
Despite the remarkable properties of azobenzenes and its utility in reversible 
photoswitching of nucleic acid-related activities, there are some drawbacks arising from 
the non-nucleosidic nature of the attached azobenzene. In other words, azobenzene is not 
able to form hydrogen bonding with nucleobases and it undergoes stacking interactions 
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with the nucleotides that differ from the stacking interaction that occurrs among the 
natural nucleotides and consequently led to change in its structural features. Recently, it 
was reported that incorporation of azobenzene into DNAzymes and ribozymes lead to 
loss of its catalytic activity due to interfering with the active site.
7 
4.2 Result and discussion 
In this work we aimed to synthesize novel photochromic nucleosides for DNA and RNA 
synthesis bearing azo-moiety as a solution to circumvent the aforementioned limitations 
observed in azobenzene-based oligonucleotides. The synthesized photochromic 
nucleosides are characterized by their ability to form hydrogen bonding with nucleosides 
obeying Watson-Crick base pairing rules with potential quenching properties based on 
the results shown in chapter 3. This goal was achieved by utilizing the naturally occurring 
uracil as starting material to maintain hydrogen bonding ability with the complementary 
nucleobase adenine (A), and via chemical transformations to introduce phenylazomoiety 
to uracil.  
As outlined in (Scheme 4-1), the synthetic route to synthesize the azo-uracil 
phosphoramidite IV-4 was started with reaction of azo-modified uracil III-1 with            
1-chloro-3,5-di-O-p-toluoyl-1,2-dideoxy--D-ribofuranose under basic conditions to 
yield the corresponding protected deoxyriboside IV-1 in 63% yield. Removal of the 
toluoyl protecting groups was carried out with sodium methoxide in methanol giving the 
2-deoxyriboside IV-2 in 79% yield. Standard methods were used to convert the 
unprotected nucleosides to 5`-dimethoxytrityl-protected derivative IV-3 by using 
dimethoxytrityl chloride (DMTCl) in pyridine giving the product in 63% yield. This was 
followed by conversion to the corresponding cyanoethyl phosphoramidite derivative IV-4 
in 81 % yield after column chromatography purification. 
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Scheme ‎4-1: Synthesis of uracil phosphoramidite possesses phenylazo moiety for 
photoswitching. 
To get an access for RNA chemistry, ribonucleoside IV-5 was synthesized as outlined in 
(Scheme 4-2) following Vorbrüggen procedure
8
 starting with refluxing III-1 with 
hexamethyldisilazane (HMDS) and trimethylsilyl chloride (TMSCl) to form the 
corresponding silylated nucleoside followed by coupling with 1-O-acetyl-2,3,5-
tribenzoyl--D-ribofuranose in dimethylformamide (DMF) in the presence SnCl4 to 
afford IV-5 in 71% after column chromatography purification. Removal of benzoyl 
groups was carried out by ammonia in methanol to yield azo-based riboside IV-6 in 86% 
yield. 
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Scheme ‎4-2:  Synthesis of photochromic riboside. 
4.2.1 Photoisomerization studies 
Azobenzene is well known to photoisomerize from its planar trans isomer to the non-
planar cis isomer after UV-light irradiation (300nm ~ 400nm), and back to the tran-
isomer upon irradiation with visible light (> 400nm) or thermally. This process is 
completely reversible under UV and visible irradiations. Based on this observation, the 
the synthesized nucleosides carrying 4-(N,N-dimethylamino)azophenyl moiety are 
expected to follow the same behavior that azobenzene follows as demonstrated in (Fig. 
4-2).   
 
Figure ‎4-2: Schematic representation of reversible trans-cis photoisomerization   
                    of the photochromic nucleoside IV-2 and IV-6. 
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To assess the photochromic behaviour of the synthesized nucleosides IV-2 and IV-6 by 
monitoring the changes that may occur at their absorption with response to irradiation. 
As can be seen from (Fig. 4-3), the absorption spectrum of trans isomer has a major 
peak centered at 454 nm (in dichloromethane for IV-2) and at 443 nm (in acetonitrile 
for IV-6) attributed to strong -* transition which overlapped with the weak peak 
attributed to weak n-* transition. By irradiating with UV-light at 366 nm, a decrease 
in the intensity of the absorption band was observed along with the irradiation time due 
to trans-to-cis isomerization, while the reverse cis-to-trans isomerization was achieved 
via thermal relaxation. 
 
 
 
 
 
 
 
 
 
 
 
Figure ‎4-3: Absorption spectra of A) IV-2 in ethanol and B) IV-6 in                
acetonitrile at 10 M concentrations for trans-to-cis photoisomerization upon 
illumination with UV-light at 366 nm. 
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4.2.2 pH-Sensitivity  
Azobenzenes derivatives especially aminoazobenzene and 4-(N,N-dimethyl- 
amino)azobenzene attracted much attention due to their ability to change colour in 
solution with the changing of the pH. It is well established that protonation of 
aminoazobenzene derivatives led to the formation of two tautomeric azonium and 
ammonium forms.
9a,b
 The azonium ion is obtained by protonation on azo-nitrogen 
leading to delocalized of the lone-pair electrons of the aromatic ring and as 
consequence a red shift in absorption maximum was occurred. Ammonium ion is 
obtained by protonation at amino-nitrogen resulting in prevention the conjugation of 
electrons lone-pairs and thusly the UV-Vis spectrum looks similar to that of 
unsubstituted azobenzene due to diminish the effect of amino substituent. 
 
Figure ‎4-4: Structure of 4-(N,N-dimethylamino)azophenyl(deoxy)uridine    
                    and its  protonated forms. Sugar was removed for simplicity. 
As mentioned in chapter 3, the presence of an azo- and dimethylamino groups in the 
synthesized nucleosides promoting us to study the effect of acid. We investigated the 
effect of trifluoroacetic acid solution (0.005 M) in dichloromethane and ethanol on the 
nucleosides IV-2 and IV-6 respectively. Matazo and coworkers
10 
have studied the 
effect of acid on 
 
4-(N,N-dimethylamino)azobenzene, they observed that absorption 
band appears at max 411 nm in acetonitrile which is attributed to neutral trans 4-(N,N-
dimethylamino)azobenzene, upon protonation this band was red shifted to max 535 nm 
with appearance of absorption band at max 318 nm. They have assigned the two bands 
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to the azo-protonated (azonium) and amino protonated (ammonium) of trans-4-(N,N-
dimethylamino)azobenzene, respectively, based on quantum-chemical calculations and 
resonance Raman spectra. 
Similarly, as can be seen in (Fig. 4-5), upon addition of TFA solution to deoxyriboside 
IV-2 in dichloromethane leads to a decrease in the -* absorption band at max 455 nm 
which is attributed to the neutral form with an increase in -* absorption bands 
centered at 618 and 350 nm attributed to azonium and ammonium ions respectively. 
There are two isosbestic points were observed at 376, 507 nm indicate that IV-2 exists 
either as non-protonated or protonated species in tautomeric equilibrium. While, upon 
titrating of IV-6 with small aliquots of TFA in ethanol, the -* absorption band for 
neutral form at max 436 nm was decreased with appearance of new absorption bands 
centered at 623 and 342 nm attributed to the protonated forms azonium and ammonium 
ion respectively. These results are in excellent agreement with the aforementioned 
study. Surprisingly, subjecting solutions of IV-2 and IV-6 in halogenated solvents as 
dichloromethane or chloroform to TFA leads to colour change from yellow to deep 
blue colour while using solvents as ethanol, methanol, and ethyl acetate instead this 
colour change was not observed.   
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Figure ‎4-5: Changes in UV-Vis spectra of A) IV-2 and C) IV-6 upon addition of 
increasing concentrations of TFA, arrows indicate the progressive decrease of 
absorption band for neutral form and the growth of protonated form. B, D) 
Variation of absorbance vs TFA concentration for the respective absorption bands. 
4.3        Conclusion  
We have successfully designed and synthesized novel photochromic azo-based 
nucleosides. These nucleosides showed the ability to undergo trans-to cis isomerization 
upon irradiation with visible light at 366 nm and reversibly the trans configuration was 
recovered thermally in the dark. In addition, the synthesized photochromic nucleotides 
showed halochromic effect upon acid treatment. Therefore, they may be contributing in 
photoregulation of nucleic acids. To the best of our knowledge, this is the first example 
of azo-based (deoxy)uridine derivatives posses intrinsic photoswitching property. 
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4.4 Experimental 
General consideration. All solvents and chemicals were commercially available and 
were used as purchased. Reactions were monitored by thin layer chromatography (TLC) 
on pre-coated 0.2 mm Merck Kieselgel 60 TLC plates. Silica gel 60 F254 (Merck) plates 
and visualized with an ultraviolet light source at 254 nm. Silica gel (Merck Kieselgel 60, 
15-40 mm) was used for column chromatography. 
1 
H NMR, 
13
C NMR and 
31
P NMR 
spectra were recorded at a Varian Mercury Plus spectrometer (400.09 MHz, 100.61MHz 
and 242.9 MHz respectively) at room temperature. Chemical shifts are reported in parts 
per million (δ), were measured from tetramethylsilane (0 ppm) and are referenced to the 
residual proton in the deuterated solvent: CDCl3 (7.26 ppm), DMSO-d6 (2.48 ppm), 
CD3OD (2.04 ppm) for 
1
H NMR and CDCl3 (77.0 ppm), DMSO-d6 (39.5 ppm) and 
CD3OD (49.1) for 
13
 C NMR. Multiplicities are described as s (singlet), d (doublet), m 
(multiplet), and br s (broad singlet). Coupling constants (J) are reported in Hertz (Hz).  
5-[4-(N,N-Dimethylamino)phenyl]diazenyluracil III-1 
To a cold solution of 5-aminouracil (1.0 g, 7.87 mmol) in 
hydrochloric acid 1N (15 mL), a solution of 6.9% NaNO2 (6 mL) 
was added dropwise over a period of 15 min. a pal yellow solid 
was precipitated. The reaction mixture was stirred for further 30 
min for complete precipitation. Solid was collected by filtration, wash with iced water 
and was dried under vacuum to give 5-diazouracil (1.04 g, 84%) and used for the next 
step without further purification. A suspension of 5-diazouracil (0.5 g, 3.2 mmol) in 
anhydrous acetonitrile (50 mL) was purged with N2 for 10 min, borontrifluoride etherate 
(0.41 mL, 3.2 mmol) and  N,N-dimethylaniline (0.38 mL, 3.2 mmol) were added to the 
mixture and was stirred for 2 h. The separated solid was filtered and refluxed in EtOH 
(100 mL) for 1 h The solid was collected and dried to afford (1.38 g, 80%) of  IV-1. 
1
H 
NMR (DMSO-d6)  : 11.42 (s, 1H), 11.28 (s, 1H), 7.66 (s, 1H), 7.61 (d, J = 8.9 Hz, 2H),  
6.79 (d, J = 8.7 Hz, 2H), 3.01 (s, 6H);  
13
C NMR (DMSO-d6)  : 161.8, 152.7, 151.3, 
143.5, 130.7, 129.5, 124.9, 112.2, 47.6. HRMS (EI): calcd. for C12 H13 N5O2 [M
+
] 
259.1069 found 259.1062. 
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5-[(4-(N,N-dimethylamino)phenyl)diazenyl]-3, 5-di-O-(p-toluoyl)-2-deoxyuridine 
IV-1  
To a suspension of 5-((4-(N,N-dimethylamino)phenyl)diazenyl) 
uracil (0.44 g, 1.72 mmol ) in dry THF (20 mL), NaH (60% 
dispersion in mineral oil, 82 mg, 3.44 mmol) was added  and stirred 
at r.t. for 2 h. A solution of 1--Chloro-3,5-di-O-toluoyl)-2-
deoxyribose
 
(0.69 g, 2.23 mmol) in dry THF (5 mL) was added to 
the mixture in one portion and the reaction mixture was stirred for 24 h under an 
atmosphere of N2. Solvent was evaporated under vacuum and the residue was dissolved 
in dichloromethane (30 mL), was washed with saturated aqueous sodium Na2CO3, brine 
and dried over anhydrous Na2SO4. The solution was filtered, concentrated, and the 
residue was subjected to purification by flash chromatography with CH2Cl2/CH3OH 
(20:1, v/v) as eluent to give bis-toluoyl ester IV-1 as red solid. The product was obtained 
as a mixture of two isomers (0.65 g, 63%). 
1
HNMR (DMSO-d6) : 11.78 (br s, 1H), 8.02 
(s, 1H), 7.92-7.89 (m, 2H), 7.80 (d, J = 7.8 Hz, 1H), 7.68 (d, J = 8.2 Hz, 1H), 7.50 (d, J = 
8.9 Hz, 1H), 7.37-7.33 (m, 3H), 7.16 (d, J = 8.2 Hz, 1H), 6.91 (d, J = 8.2 Hz, 1H), 6.75 
(d, J = 8.9 Hz, 1H), 6.69 (d, J = 9.3 Hz, 1H), 6.32  (m, 1H), 5.57 ( d, J = 5.8,1H), 5.01 
(m, 1H), 4.57 (m, 1H), 4.41 (m, 1H), 3.02 (s, 6H), 2.97 (m,1H), 2.61 (m, 1H), 2.37 (s, 
3H), 2.26 (s, 3H); 
13
C NMR (CDCl3)  : 166.1, 165.7, 152.2, 144.3, 143.5, 129.8, 129.6, 
129.1, 126.5, 126.6, 126.3,125.7, 111.2, 87.9, 77.3, 74.6, 64.1, 40.1, 27.96. HRMS (EI): 
calcd. 611.2380 for C33H33N5O7 [M
+
]
 
found 611.2391. 
5-[4-(N,N-dimethylamino)phenyl)diazenyl]-2-deoxyuridine IV-2.  
 To a cold solution of the toluoyl ester IV-1 (0.5 g, 0.82 mmol) in dry 
CH2Cl2 (5 mL), NaOMe solution (0.2 M in MeOH) (9.8 mL, 1.96 
mmol) was added dropwise over 15 min. The reaction mixture was 
stirred at r.t. for 1 h.  An aqueous solution of 5% NH4Cl was added to 
the mixture till the pH was 8 and the mixture was extracted with 
ethylacetate (3 x 30 mL). The combined organics were washed with brine, dried over 
anhydrous Na2SO4 and concentrated under reduced pressure to afford red oil residue. The 
108 
 
residue was subjected to flash chromatography using hexane/ CH2Cl2 (70:30, v/v) as the 
eluent to yield the deoxyriboside  IV-2 as red powder (0.25 g, 79%). 
1
H NMR (CD3OD) 
: 8.50 (s, 1H), 7.79 (d, J = 7.8 Hz, 1H), 6.77 (d, J = 7.8 Hz, 1H),  6.33 (t, J = 6.5 Hz, 
1H), 4.43 (m, 1H), 3.96 (m, 1H), 3.83 (m, 1H), 3.75 (m, 1H), 3.20 (dd, J = 3.3 and 7.3 
Hz, 1H), 3.03 (s, 6H), 2.40 (m, 2H); 
13
CNMR (CD3OD): δ 163.5, 154.3, 151.5, 131.2, 
126.4, 112.7, 89.3, 87.4, 72.1, 62.7, 41.8, 40.5. HRMS (EI): calcd. 375.1543 for 
C17H21N5O5 [M
+
]
 
found 375.1535.  
5-[4-(N,N-dimethylamino)phenyl)diazenyl]-2-deoxy-5-O-(p, p-dimethoxytrityl)   
uridine IV-3 
The free nucleoside IV-2 (0.2 g, 0.54 mmol) was dried by             
coevaporation with dry pyridine (3 x 5 mL) and then was 
dissolved in dry pyridine (10 mL). A solution of 4,4´-dimethoxy- 
tritylchloride (0.269 g, 0.69 mmol) in dry pyridine (5 mL) and 
DIPEA (7.0 mmol, 1 mL) was added and the mixture was stirred 
at r.t. for 3 h. The reaction mixture was quenched by the addition of methanol (2 mL), 
was diluted with CH2Cl2 (75 mL) and then was washed with saturated aqueous solution 
of NaHCO3 (3 x 50 mL). The organics were combined, dried over anhydrous Na2SO4 and 
filtered. The solvent was removed under reduced pressure to give red oil. The crude 
product was purified by flash column chromatography using CH2Cl2/ MeOH/ Et3N (85: 
10: 5, v/v) as elution solvent afforded the tetritylated derivative IV-3 as red solid (0.28 g, 
63%). 
1
H NMR (CDCl3) δ: 8.25 (s, 1H), 7.65 (d, J = 8.9 Hz, 2H), 7.38 (d, J = 7.4Hz, 2H), 
7.27 (d, J = 7.4 Hz, 4H), 7.22 (d, J = 7.0 Hz, 2H ), 7.14 (m, 2H), 6.78 (d, J = 8.5 Hz, 3H), 
6.51 (d, J = 8.5 Hz, 2H), 6.18 (m, 1H), 4.57 (m, 1H), 4.39 (m, 1H), 3.69 (s, 6H), 3.20 (m, 
1H), 3.25 ( m, 1H), 2.90 (s, 6H), 2.80 (m, 1H) 2.47 (m, 1H); 
13
C NMR (CDCl3) δ: 161.4, 
158.3, 152.0, 149.7, 144.5, 143.3, 135.6, 135.39, 130.4, 129.8 , 127.9, 127.7, 126.6, 
125.0, 113.0, 111.1, 89.1, 86.2, 71.9, 64.1, 55.0, 45.6, 40.0. HRMS (ESI): calcd. 
678.2928 for [MH
+
]
 
C38H40N5O7 found 678.2906. 
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5-[4-(N,N-dimethylamino)phenyl)diazenyl]-2-deoxy-3-(2-cyanoethyldiisopropyl 
phosphoramidite)-5-O-(p,p-dimethoxytrityl)uridine IV-4 
To a solution of DMT-deoxyuridine IV-3 (0.16 g, 0.24 mmol) in 
dry CH2Cl2 (5 mL), DIPEA (340 μL, 2.4 mmol), 2-cyanoethyl-
(N,N-diisopropylamino) chlorophosphite (105 μL, 0.47 mmol) was 
added. The reaction mixture was stirred at r.t. under ambient 
atmosphere for 3 h until deemed complete by TLC. Solvent was 
removed and the resultant residue was dissolved in CH2Cl2 (25 
mL), washed with aqueous solution of 5% NaHCO3 (25 mL), brine (20 mL) and was 
dried over anhydrous Na2SO4. After removal of solvent the crude product was subjected 
to flash chromatography using hexane/ ethylacetate/ Et3N (80:15: 5 to 50:45:5, v/v) to 
yield the phosphoramidite derivative IV-4 (0.169 g, 81%). 
1
H NMR (CDCl3) δ : as two 
diastereomers: 8.19 and 8.17 (2s, 1H), 7.77 (d, J = 7.6 Hz, 2H), 7.38 (d, J = 7.6 Hz, 2H), 
7.21 (m, 7H), 6.79 (d, J = 6.7Hz, 4H), 6.63 (d, J = 6.5 Hz, 2H), 6.29 (m, 1H), 4.80 (m, 
1H), 4.54-4.46 (m, 2H), 3.75 (s, 6H), 3.57-3.48 (m, 2H), 3.03 (s, 6H), 3.38 (m,1H), 3.11 
(m, 1H), 2.85 (m, 2H), 2.38-2.17 (m, 2H), 1.20 (s, 12H); 
13
C NMR (CDCl3) δ : 160.8, 
158.5, 152.3 149.5, 144.3, 143.5, 135.5, 129.9, 128.0, 126.9, 125.1, 113.2, 111.2, 88.7, 
85.5, 74.1, 67.1, 55.0, 43.0, 40.2, 32.2, 29.6, 26.3, 24.4, 23.38; 
31
P NMR (CDCl3): δ two 
diastereomeric peaks at 149.2 and 148.6. HRMS (ESI): calcd. 878.3880 for [MH
+
]
 
 
C46H55N8O8P, found 878.3889. 
5-[(4-(N,N-dimethylamino)phenyl)diazenyl]-1-(2, 3, 5-tri-O-benzoyl--D-
ribofuranosyl)]uridine IV-5 
A suspension of 5-((4-(N,N-dimethylamino)phenyl)diazenyl)uracil 
III-1 (0.26 g, 1 mmol) in of 1,1,1,3,3,3-hexamethyldisilazane 
(HMDS) (20 mL) and of trimethylsilyl chloride (1 mL) was 
refluxed until a clear solution was obtained. The solution was 
allowed to cool, and excess HMDS was removed under reduced 
pressure. The silylated uracil derivatives were dissolved in CH3CN (5 mL) and the 
solution was burged with nitrogen for 15 min prior to addition of SnCl4 (10% excess) 
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(127 L, 1.2 mmol) to the reaction mixture with vigorous stirring. A solution of 1-O-
acetyl-2,3,5-tri-O-benzoyl--D-ribofuranose (0.56 g, 1.1 mmol) in CH2Cl2 (20 mL) was 
added dropwise to the reaction mixture. The solution was stirred at r.t. for 6 h at which 
the reaction came to completion as determined by TLC. The reaction mixture was 
quenched by aqueous saturated NaHCO3 solution (100 ml) and was extracted with 
CH2Cl2 (3 x 50 ml) and was dried over anhydrous Na2SO4. The solvent was removed 
under reduced pressure leaving brown residue. The crude product was purified by flash 
column chromatography using elution with a gradient of hexane/ CH2Cl2 (from 100:0 to 
60:40, v/v). Compound IV-5 was isolated as a red solid (0.5 g, 71%). 
1
H NMR (CDCl3) 
: 9.86 (br s, 1H), 8.05 (s, 1H), 7.96 (d, J = 7.4, 2H), 7.91 (d, J = 7.0, 2H), 7.70 (d, J = 
7.4, 3H), 7.49 (m, 4H), 7.32 (m, 6H), 6.66 (d, J = 7.0, 2H), 6.29( m, 1H), 4.82 (m, 1H), 
4.72 (m, 3H), 3.06 (m, 1H), 3.03 (s, 6H); 
13C NMR (CDCl3) δ: 166.2, 165.3, 160.6, 
152.7, 149.4, 143.4, 133.8, 133.4, 129.9, 129.8, 128.5, 125.5, 111.2, 88.6, 80.9, 74.2, 
71.5, 64.2, 40.2. HRMS (ESI): calcd. for C38 H34 N5O9 [MH
+
] 704.2357 found 704.2358. 
5-[(4-(N,N-dimethylamino)phenyl)diazenyl]uridine IV-6 
Compound IV-5 (0.4 g, 0.57 mmol) was dissolved in saturated 
solution of ammonia in methanol (20 mL) and was stirred for 4 h 
at r.t. The solution was evaporated under pressure to give the crude 
product which was purified by flash column chromatography using 
CH2Cl2/MeOH (90: 10,v/v) yielding 0.19 g (86%). 
1
H NMR 
(DMSO-d6) : 7.73 (s, 1H), 7.64 (d, J = 8.9, 2H), 6.78 (d, J = 8.9, 2H), 6.14 (m, 1H), 
5.07 (m, 1H), 4.90 (m, 1H), 4.62 (m, 1H) (Exchangeable 3OH), 4.52 (m, 1H), 4.12 (d, J = 
5.4, 1H), 3.69 (m, 1H),  3.62 (m, 2H), 3.44 (m, 1H),  3.01 (s, 6H); 
13
C NMR (DMSO-d6) 
δ: 160.8, 152.5, 143.2, 124.8, 111.9, 94.9, 84.9, 71.4, 70.6, 63.7, 62.79, 40.5. HRMS 
(ESI): calcd. for C17H21N5NaO [M
+
]  414.1390 found 414.1382. 
UV-Vis measurments: 
All UV-Vis spectra were measured with a Varian Cary 300 Bio spectrophotometer using 
quartz cuvette cells of 1 mm of optical path. 
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Photoisomerization. 
 Trans-to-cis photoisomerization of nucleosides IV-2 and IV-6 were monitored by UV-
Vis spectroscopy. A solution of the nucleosides at 1.06 x10
-5 
M concentration (IV-2 in 
dichloromethane) and (IV-6 in acetonitrile) were irradiated with UV-light at room 
temperature using a UVGL-58 hand held lamp (6 watt, 366 nm) at A distance of 
approximately 5 cm. The spectral change for absorption maximum peak at 455 nm (for 
IV-2) and 436 nm (for IV-6) were monitored with the time course of irradiation. While 
the cis-to-trans isomerization was achieved and confirmed by retrieving the maximum 
absorption bands at 455 nm (for IV-2) and 436 nm (for IV-6) thermally by leaving the 
samples at the dark at room temperature.  
Effect of acids 
The spectral change of the synthesized photochromic nucleosides at concentration 
6.2x10
-6 
M (in dichloromethane for IV-2) and 1.5x 10
-5 
M (in ethanol for IV-6) were 
monitored upon addition of small aliquots of TFA solution (0.005 M).   
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Chapter 5  
5 Synthesis of Acridine-Based PNA Monomer Suitable for 
PNA-Fluorescent Probes. 
It is well known that the stability of nucleic acid double helical structure (DNA:DNA, 
DNA:RNA, PNA:DNA, PNA:RNA and PNA:PNA) relies on many intermolecular 
interactions such as hydrogen-bonding between nucleotides, -stacking interactions, 
solvent effect.  
5.1 Hydrogen bonding 
Generally, a hydrogen bond is formed between hydrogen atom covalently attached to an 
electronegative atom (donor atom) and an electronegative atom (acceptor). In 
nucleobases H-bonds mainly form between N-H····N or/and N-H····O of complementary 
nucleotide base pairs. H-bond formation mechanistically can be described by interactions 
of lone-pair orbitals on O or N of one nucleobase with * orbital of N-H.1 Despite the H-
bond being very weak compared to covalent bonds, formation of many H-bonds between 
complementary nucleotides in two DNA strands is sufficiently strong enough to keep the 
two DNA strands in duplex structure.  
Several reports show that the stability of the nucleic acid structures benefit from 
increasing the number of hydrogen bonds sites in nucleobases. Simply, this can be 
achieved by modifying naturally occurring nucleobases. Diaminopurine (DAP), an 
adenine analogue, is characterized by its ability to pair with thymine by three hydrogen 
bonds (only two hydrogen bonds between A:T)  (Fig. 5-1). 
 
Figure ‎5-1: Base pairing between DAP:T comparing to A:T . 
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Another example was introduced from our lab is (mono-ortho-(aminoethoxy)phenyl) 
pyrrolocytosine (moPhpC). This modified cytosine is able to base pairing with guanine 
by formation of four hydrogen bonds. The design of moPhpC is characterized by the 
extending aromatic ring system of pyrrolocytosine that will improve -stacking in 
addition to  presence of aminoethoxy linker that provides a new site for formation of H-
bonds with  O(6) of guanine via Hoogsteen base pairing. Incorporation of moPhpC into a 
10-mer PNA with the sequence GTAGATXACT-Lys (X= moPhpC) resulted in an 
increase in the stability of DNA and RNA duplexes by (+10.5C) and (+4 C), 
respectively, which was rationalized by the formation of an additional hydrogen bond to 
guanine (Fig. 5-2).
2
  
 
 
Figure ‎5-2: Hybridization of cytosine (left) and its modification moPhpC (right) 
with guanine to demonstrate the effect of increasing of H-bonds on the stability of 
duplex.  
 
5.2 Base-stacking 
In base stacking there are no covalent interactions between the nucleobases in a dsDNA 
structure. In most of all known DNA structures the bases are found to have face-to-face 
interaction due to their planar structure. There are many factors affecting -stacking such 
as Van der Waals dispersive forces between bases, permanent electrostatic effects of 
interacting dipoles and solvation effects.
3
 A number of studies have proved base-stacking 
contributes significantly to the stabilization of DNA and RNA helical structure. For 
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example, Turner and coworkers
4
 have found that double-helical structure of short RNA is 
stabilized by introducing unpaired base at the end. This study was based on the 
dangling-end effect.  
5.3 Fluorescent nucleobases 
Since 1980’s, much effort has been devoted to exploit using fluorescence techniques in 
detection of nucleic acids. Aromatic-based amino acids (phenylalanine, tyrosine and/or 
tryptophan) are characterized by their intrinsic fluorescence that may be used in 
fluorescent studies; but natural nucleic acids are known to be nonfluorescent.
5a,b
 Due to 
the promising results shown for detection of nucleic acid using fluorescent probes, 
intensive research has been devoted to design and synthesize nucleobases possessing 
fluorescent properties. There is a great demand for such nucleobases, especially ones that 
are fluorescent while maintaining the hydrogen bonding ability to the complementary 
nucleobases.  
Fluorescent nucleobases are classified by Tor
6
 into five major families as 1) isomorphic 
base analogues, 2) pteridines, 3) Expanded nucleobases, 4) chromophoric base analogues 
and 5) conjugated base analogues. In the following paragraphs a brief details are given 
for each family.  
1) Isomorphic base analogues, heterocyclic compounds characterized by its similarity to 
the natural nucleobases in overall dimension and their ability to Watson-Crick base 
pairing. The most common example of this class is 2-aminopurine (2-AP). 2-AP is an 
analog of guanine and adenine and therefore it can pairs with thymine and uracil obeying 
Watson-Crick
7
 base pairing and with cytosine by Wobble base pairing
8 
as shown in 
(Fig.5-3). 2-AP is distinguished by its high fluorescence quantum yield (F = 0.68 in 
aqueous solution) and high sensitivity to the local environment. Upon incorporation of 2-
AP into nucleic acid, the fluorescence intensity of 2-AP was drastically reduced ~ 100 
times due to stacking interactions with nearest neighbor nucleobases. This reduction in 2-
AP quantum yield is highly dependent on base sequence.
9
 Owing to 2-AP sensitivity to 
microenvironment, it has been widely used in several studies of nucleic acid structure and 
dynamics within DNA,
10 
and RNA.
11
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Figure ‎5-3:Represntation of hybridization of 2AP with natural base complements  
                    thymine and cytosine. 
 
2) Pteridines, purine analogues, are bicyclic planar  compounds formed from two 
condensed six membered rings and are distinguished by their ability to form hydrogen 
bonds with complementary bases in addition to their intensive emission quantum yield 
(F = 0.77-0.88 for adenosine analogues and 0.39-0.48 for the guanosine)
12 
(Fig. 5-4). 
Pteridines have been employed in numerous applications as hybridization probes which 
are used in measuring the cleavage activity of the retrovirally coded protein, human 
immuneodeficiency virus-1 (HIV-1) integrase (IN).
13 
Another example of using pteridine 
probes (using 6MAP as replacement of A-residues) in detection of A-tract structure.
14
  
 
 
Figure ‎5-4: Strcutures of some pteridine derivatives. 
 3) Expanded nucleobases, are natural nucleobases that have been extended with fused 
aromatic rings. Etheno-A,
15
 the simplest example of fluorescent extended nucleobases 
with quantum yield = 0.54 (in dioxane-H2O 1:1), it was prepared by reaction of 
chloroacetaldehyde with adenosine. Despite the fluorescence property of Etheno-A, it can 
not engage in hydrogen bonding. Much work has been done to extend the nucleobases 
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structures while retaining their ability to hydrogen bond with complementary nucleobases 
(Fig.5-5).
16
 
 
 
Figure ‎5-5: Examples of expanded nucleobases.  
 
 4) Chromophoric base analogues, are produced when the natural nucleobases are 
replaced by hydrocarbons and heterocyclic residues that are characterized by their 
emission such as pyrene, phenanthrene, terphenyl, terthiophene, benzoterthiophene and 
coumarin (Fig. 5-6).
17
 Using multiple dyes as replacement of DNA bases in adjacent 
position in a DNA sequences can be used in detection of genetic sequence. For example, 
pyrene is a well-characterized excimer-forming fluorophore. When it is used alone it 
emits blue light while using two units of pyrene leads to emission of green light ascribed 
to the formation of an excimer complex through energy transfer from one pyrene unit to 
the other. Kool and coworkers
18
 have exploited this colour change of pyrene upon 
excimer complex formation in detection of a portion of a gene. This was achieved by 
synthesis of two single pyrene-labeled strands at 3` and 5` ends and these strands were 
designed to be a complementary to a portion of the gene under study. Upon hybridization, 
the two pyrene units are located in adjacent position and thusly change fluorescence 
colour due to formation of excimer.  
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Figure ‎5-6: Examples of hydrocarbons and heterocyle DNA base replacement. 
 
5) Conjugated base analogues, are the fluorescent aromatic residues that are conjugated 
to the nucleobases via a linker. This class is characterized by introducing fluorecent 
property from the aromatic residue and maintaining the hydrogen bond ability with their 
complementary nucleobase. 5-alkynyluracil derivatives
19a-f
 are good examples of this 
class were reported by several groups their synthesis is based on Sonogashira cross 
coupling reaction. Hudson and coworkers
19a
 have exploited mismatch detection by          
5-ethynyldeoxuridine derivatives, it was found that the greatest fluorescence response (6 
fold increase in fluorescence intensity with matching sequence) was observed for the 
oligomer containing p-methoxyphenylethynyluracil unit (Fig. 5-7).    
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Figure ‎5-7: Structures of some conjugated base analogues used in DNA and RNA 
probe. 
5.4 Acridine 
Acridine is a heterocyclic analog of anthracene where the central CH group is replaced by 
nitrogen atom as shown in (Fig 5-8). Acridine derivatives have been known since 19
th
 
century but they have attracted much interest after World War I when they were used as 
antibacterial and antimalarial agents.
20,21
  
Acridine derivatives have been employed for targeting several biological targets as 
topoisomerases I and II, telomerase/telomere and protein kinases.
22
 The biological 
activity of the acridines is mainly ascribed to their planar configuration that allow them y 
to intercalate within the double-stranded DNA structure leading to interference with the 
cellular machinery.  
Several acridine-based drugs are reported in literature proved their ability as anticancer, 
antibacterial and antimalarial agents. For example, Amsacrine (m-AMSA), was designed 
by Denny and coworkers
23
 and it was the first drug has been proved to bind with topo II-
122 
 
DNA complex by intercalation.
24
 Chourpa and coworkers
25
 confirmed by using surface-
enhanced Raman scattering (SERS) spectroscopy that the side chain located at the meta-
position participates in an additional specific interaction with topo II-DNA complex. It is 
well established that acridine derivatives can bind to DNA and RNA through 
intercalation of the acridine ring between adjacent base pairs in the DNA duplex.
26-a-c
 
Acridine units are held in their positions by: 1) strong ionic bonds  between the 
protonated acridine-nitrogen atoms and the phosphate ions of DNA backbone and  2) van 
der Waals forces between acridine unit and the base pairs.  
 
Acridine derivatives have been extensively used for labeling oligonucleotide probes, 
acridine orange (AO) is an example of fluorescent acridine derivative which is also 
characterized by its affinity to nucleic acids. In aqueous solution, AO has been shown to 
exist in two forms: 1) one is distinguished by an absorption maximum band at 494 nm 
and green fluorescence maximum band at 530 nm this form was found in highly-diluted 
solutions (10
-7 
M)  attributed to presence of acridine as single monomers. 2) the other 
form is characterized by an absorption maximum band at 465 nm and red fluorescence 
maximum band at 640 nm this form was found in highly-concentrated solutions (> 10
-2 
M) this is ascribed to presence of acridine as dimers.
27
 AO was used for discriminate 
between dsDNA and ssDNA through enhancement of fluorescence upon dsDNA binding 
whereas AO intercalates into dsDNA while it binds to ssDNA electrostatically.
28
 
 
Figure ‎5-8: Structure of acridine, m-AMSA and acridine orange (AO). 
Based on the aforementioned properties of either acridine as a fluorogenic molecule or 
peptide nucleic acid (PNA) as artificial nucleic acid analog with remarkable binding 
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ability, we interested in synthesis of PNA monomer possessing acridine moiety. 
Incorporation of acridine-based PNA monomer in PNA oligomer may be used as reporter 
probe for DNA detection in addition to its potential stabilization of duplex structure. 
5.5 Results and discussion  
The synthesis of the acridine-based PNA monomer is illustrated in (Scheme 5-1). Started 
with the synthesis of 9-chloroacridine (V-1) from N-phenylanthranilic acid and 
phosphoryl chloride according to the reported method.
29
 In the next step, 9-chloroacridine 
was refluxed with 5-aminouracil in the presence of phenol to afford 5-(acridin-9-
ylamino)uracil V-2 in 85% yield. The ethyl ester derivative V-3 was obtained in 65% 
yield by alkylation of V-2 at N-1 position with 2-ethyl bromoacetate in DMF in the 
presence of anhydrous K2CO3. V-3 underwent hydrolysis using aqueous NaOH (2.5 M) 
in THF to give the acetic acid derivative V-4 in 93%. Carbodiimide mediated coupling of 
V-4 with N-[2-(Fmoc)aminoethyl]glycine-t-butyl ester was accomplished using 
EDC/HOBt, to give the protected monomer ester V-5 in 71 % yield. Finally, removal of 
t-butyl group was carried out by acidolysis using TFA to give the acridine-containing 
PNA monomer V-6 in 90% yield. 
 
 
Scheme 5-1: Synthesis of acridine-based PNA monomer. 
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5.5.1 Photophysical properties 
UV-Vis spectra of acridine-based PNA monomer have been investigated under different 
solvents (Table 5-1), there is no clear trend between solvent polarities to the absorption 
maximum of V-6. It is well established that acridine moity is amenable for protonation 
forming acridinum cation (AcH
+
). The effect of acid on comound V-6 has been 
investigated by UV-Vis as shown in (Fig 5-1). Treatment of V-6 in various solvents with 
trifluoroacetic acid casued a red shift of the maximum absorption band, interstingly this 
shift was accopained by an increasing of the absorption intensity.  
 
Table ‎5-1: Photophysical properties of V-6 
 
 
 
 
 
 
 
Figure ‎5-9: UV-Vis spectrum of V-6 (2.6 M) neutral and acidic form in a) CH3CN         
                     and b) Dioxane   
 
Solvent  DCM dioxane Acetone EtOH CH3CN 
max (Neutral) nm 404 406 412 409 402 
max (Protonated) nm 434, 443 427,443 430,453 417, 437 418, 433 
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5.5.2 Fluorescence properties of acridine-based monomer 
A preliminary fluorescence study on compound V-6 has been obtained, the acridine-
based PNA monomer showed a high quantum yield of 0.32 in ethanol and 0.43 in 
dichloromethane. A drastic decrease in the fluorescence emission is observed upon 
increasing water content as shown in (Fig. 5-10). The quenching behaviour is a good 
indication for the potential use of PNA probe contacting acridine moiety in monitoring 
binding events.  
 
 
Figure ‎5-10: Quenching of fluorescence emission of V-6 in EtOH upon addition of  
                       water. 
5.5.3 Future work 
Incorporation of acridine-based PNA monomer into PNA oligomer is underway. This 
PNA oligomer may be used as reporter probe. Based on the fluorescence quenching of 
acridine upon subjecting to aquouse environment, the acridine containing PNA prob may 
be used to monitor the state of hybridization (single stranded or duplex structure)  
5.5.4 Conclusion  
We synthesized PNA monomer carrying acridine moiety characterized by its high 
fluorescene quantum yield that may be used as reported in PNA probes with expected 
stabilization of the formed duplex structure. It was found that emission of acridine is 
sensitive to aqueous environment which indicates that PNA probe containing acridine 
moiey may be a good candidate for reporting binding events.  
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5.6  Experimental  
9-Chloroacridine V-1 
In a round bottom flask fitted with a water condenser, N-phenylanthranilic 
acid (2.0 g, 9.39 mmol) was suspended in  POCl3 (20.0 g, 47 mmol), the 
mixture was heated slowly for 15 min on water bath  at 80 C, the reaction 
mixture was transferred to oil bath and heated for 2 h at 120 C. The excess of POCl3 was 
removed by distillation under vacuum leaving the residue. Cold water (200 mL) was 
added and the residue was basified with concentrated NH4OH solution (28%, 15 mL) to 
afford the product as greenish gray solid (1.8 g, 90%). 
1
H NMR (DMSO-d6) δ: 8.40 (dd, J 
= 2.2 and 0.7, 1H), 8.38 (dd, J = 2.2 and 0.7, 1H), 8.21 (dd, J = 1.8 and 0.6, 1H), 8.19 
(dd, J = 1.8 and 0.6, 1H), 7.95(d, J = 1.4, 2H), 7.92 (d, J = 1.8 and , 2H). HRMS (EI): 
calcd. for C13H8ClN [M]
+
 213.0345,  found 213.0339 
5-(Acridin-9-ylamino)uracil V-2 
A mixture of 9-chloroacridine V-1 (0.5 g, 2.35 mmol) and phenol 
(10.0 g, 0.11 mmol) was heated at 80 °C with stirring until phenol is 
melted, 5-aminouracil (0.28 g, 2.2 mmol) was added and the mixture 
was heated at 120 °C for 2 h. The reaction mixture was cooled to room temperature and 
then was treated with dilute NH4OH (50 mL) to precipitate an orange solid. The crude 
product was collected by filtration and was crystallized from ethanol to afford compound 
V-2 (0.57 g, 85%).
1
H NMR (400 MHz, DMSO-d6) δ: 11.82 (bs, 1H), 11.24 (s, 1H), 10.87 
(s, 1H), 8.27 (d, J = 8.0, 2H), 7.57 (t, J= 7.6, 2H), 7.65 (d, J = 8.0, 2H), 7.22 (t, J = 7.6, 
2H); 
13
C NMR: 177.5, 151.1, 141.5, 134.1, 131.9, 126.7, 121.7, 121.1, 117.9. HRMS 
(EI): calcd. for C17H12N4O2 [M]
+
 304.0960,  found 304.0971. 
Ethyl-2-(5-(acridin-9-ylamino)-uracil-1-yl)acetate V-3. 
Compound V-2 (0.5 g, 1.64 mmol) was dissolved in dry DMF (8 
mL), anhydrous K2CO3 (0.68 g, 4.92 mmol) was added and the 
mixture was stirred on ice for 10 min followed by the dropwise 
127 
 
addition of ethyl-2-bromoacetate (0.3 g, 1.8 mmol) over 30 min and the reaction mixture 
was stirred for 24 h. The reaction mixture was filtered and the solvent was concentrated 
under pressure to leave yellow oil. The oil was dissolved in dichloromethane (100 mL) 
and was washed with saturated KHCO3 (2 x 50 mL), H2O (2 x 50 mL) and finally with 
brine (2 x 50 mL). The organic phase was collected and dried over anhydrous Na2SO4, 
filtered and concentrated in vacuo. The crude product was purified by flash 
chromatography with hexane/ CH2Cl2 (8:2, v/v) to yield V-3 as yellow solid (0.42 g, 
65%). 
1
H NMR (400 MHz, DMSO-d6)  : 11.42 (s, 1H), 10.97 (s, 1H), 8.25 (s, 1H), 7.94 
(d, J = 7.5 Hz, 2H),  7.49 (d, J = 7.4 Hz, 7.5 2H), 7.31 (d, J = 7.5 Hz, 2H), 7.08 (t, J =  
7.5 Hz, 2H), 4.51 (s, 2H), 4.16 (t, J =7.0 Hz, 2H), 1.20 (q, J = 7.0 Hz , 3H); 
13
C NMR 
(100 MHz, DMSO-d6)  ,177.4, 169.0, 161.9, 150.7, 150.0, 141.6, 134.1, 132.1, 126.7, 
123.1, 121.6, 121.18, 117.9, 61.2, 49.2, 14.7. HRMS (EI) m/z: calcd. for C21H18 N4O4 
[M
+
] 390.1328 found 390.1337. 
2-(5-(Acridin-9-ylamino)-uracil-1-yl)acetic acid V-4. 
The ethyl ester V-3 (0.35 g, 0.89 mmol) was dissolved in THF (25 
mL) and was kept in an ice bath for 15 min followed by the 
dropwise addition of NaOH (2.5 M, 5 mL) over 5 min with stirring. 
The reaction mixture was removed from the ice bath and was 
stirred at r.t. till completion of reaction. TLC analysis confirmed consumption of starting 
material after 20 min. The reaction mixture was transferred to separatory funnel 
containing KHSO4 (1.0 M, 50 mL) and dichloromethane (100 mL). The aqueous layer 
was further extracted with dichloromethane (3 x 50 mL). The collected organics was 
dried over anhydrous Na2SO4, filtered and concentrated in vacuo to afford the acid 
derivative V-4 as orange solid (0.3 g, 93%). 
1
H NMR (400MHz, DMSO-d6)  : 13.39 (br 
s, 1H), 11.93 (s, 1H), 11.01 (s, 1H),  8.67 (d, J = 8.6 Hz, 2H), 8.31 (s, 1H), 8.08 (d, J  = 
8.1 Hz, 2H), 7.99 (t, J  = 8.1 Hz, 2H), 7.54 (t, J = 8.1 Hz, 2H) 4.59 (s, 2H); 
13
C NMR 
(DMSO-d6)  : 170.1, 161.4, 152.8, 150.9, 143.5, 134.7, 129.6, 125.0, 112.2, 49.8. 
HRMS (ESI-TOF) m/z: calcd. for C19 H15 N4O4 [MH
+
] 363.1093 found 363.1108. 
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tert-Butyl-2- N-(2-(9-fluorenylmethoxycarbonyl)aminoethyl)-2-(5-(acridin-9-
ylamino)-uracil-1-yl)acetamido)acetate V-5. 
To  a solution of V-4 (0.20 g, 0.552 mmol) in DMF (5 mL), N-[2-
(Fmoc)aminoethyl]glycine-t-butyl ester (0.20 g, 0.5 mmol), EDC 
(0.11 g, 0.6 mmol), and HOBt (0.09 g, 0.6 mmol) was added and 
the solution was stirred for 10 min at 4 °C and at r.t. for 24 h 
under N2. The mixture was poured into iced water (25 mL) and the suspension was 
placed at 4 °C for 2 h. The precipitated solid was collected by filtration, and was purified 
by column chromato graphy using CH2Cl2 /MeOH (9.5: 0.5, v/v) as the eluent to give the 
monomer ester V-5 (0.29 g, 71%) as an orange solid. Compound V-5 exists in solution as 
a pair of slowly exchanging rotamers; signals attributed to major (ma.) and minor ( min.) 
rotomers are designated : 
1
H NMR (400MHz, DMSO-d6)  : 10.9 (s, 1H), 10.5 (s, 1H), 
8.24 (s, ma., 0.6H), 8.24 (s, mi., 0.4H), 7.89 (d, J = 7.4 Hz, 2H), 7.7 ( t, J = 8.2 Hz, 2H), 
7.6 (t, 7.3, 2H), 7.5 (m, 4H), 7.43 (t, J = 7.4 Hz, 2H), 7.34 (t, J = 7.4 Hz, 2H), 7.25 (t, J = 
7.8 Hz, 2H), 4.37 (s, 2H), 4.32 (d, J = 6.4 Hz, 2H), 4.26-420 (m, 4H),  4.14 (m, 1H), 3.91 
(s, 1H), 3.24-18 (m, 2H), 1.42 (s, mi., 2H), 1.39 (s, ma., 7H); 
13
C NMR (DMSO-d6)  
:176.8, 167.9, 166.5, 159.5, 156.4, 150.5, 143.9,143.8, 140.9, 133.4, 131.3, 127.6, 
126.0,125.0, 121.0, 120.5, 120.1, 117.3, 115.3, 80.9, 65.5, 46.7, 42.0, 41.4, 27.6. HRMS 
(EI) m/z: calcd. for C42H40N6O7 [M
+ 
] 740.2958 found 740.2943. 
2-(N-(2-(9-Fluorenylmethoxycarbonyl)aminoethyl)-2-(5-(acridin-9-ylamino)-uracil-
1-yl)acetamido)acetic acid V-6. 
To a suspension of compound V-5 (0.20 g, 0.27 mmol) in 
dry CH2Cl2 (5 mL), Et3SiH (40 L, 0.2 mmol) was added 
and cooled to 0 °C followed by dropwise addition of TFA (5 
mL) and The reaction was stirred for 30 min on ice and an 
additional 2 h at r.t. The mixture was evaporated to dryness by nitrogen stream’ the 
remaining volatiles were removed by coevaporation with CH2Cl2 and diethyl ether. The 
compound was dissolved in CH2Cl2 (3 mL), diethyl ether (50 mL) was added and cooled 
to 0 °C overnight. The precipitated product was collected by filtration and was dried 
under vacuum to obtain V-6 as orange solid (0.167 g, 90%). Compound V-6 exists in 
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solution as a pair of slowly exchanging rotamers; signals attributed to major (ma.) and 
minor (mi.) rotomers are designated : 
1
H NMR (400MHz, DMSO-d6)  : 11.77 ( br s, 
1H), 11.45 (s, 1H), 10.77 (s, 1H), 8.61 (s, mi., 0.4H), 8.59 (s, ma., 0.6 H), 8.22 (d, J = 
8.1, 1H), 8.06 (t, J = 6.2, 2H), 7.97 (d, J = 8.1,1H), 7.90 (d, J = 8.1, 3H), 7.73 ( t, J = 
7.4,1H), 7.65 (m, 4H), 7.43 (t, J = 7.0, 2H), 7.33( t, J = 7.0, 2H), 4.41 (s, 2H), 4.33 (d, J = 
6.4 Hz, 1H), ,4.29 (d, 2H), 4.26-4.16 (m, 3H), 3.89 (s, 1H), 3.22-19 (m, 2H). (HRMS 
(ESI-TOF) m/z: calcd. for C38H33N6O7 [MH
+
] 685.2411 found 685.2441. 
Quantum Yield determination  
Fluorescence quantum yields (ΦF) of the acridine based monomer was determined using a 
Photon Technologies International Quanta Master 7/2005 spectrophotometer by the 
relative method
30
 using anthracene (ΦF = 0.32) as a reference standard. The quantum 
yields were determined using emission wavelengths range between 370 and 600 nm with 
an excitation wavelength of 360 nm.The quantum yield of the unknown Φ(x) can be 
calculated by the following equation: 
ΦF(x)= Φ(ST) (AST/AX) (FX/FST) (η
2
X/η
2
ST) 
Where Φ(ST) is the quantum yield of the standard, A is the absorbance at the excitation 
wavelength, F is the integrated area in the emission curve, the subscripts X and ST refer 
to unknown and standard  respectively and η is the refractive index of the solvent. By 
measuring a series of diluted solutions with various absorbance readings the following 
equation may be used:  
ΦF(x)= Φ(ST) (GradX/GradST) (η
2
X/η
2
ST) 
Where Grad is the gradient from the plot of integrated area in the emission curve versus 
absorbance at the excitation wavelength. The validity of the methodology was confirmed 
by measuring these characterized compounds: anthracene (ΦF = 0.29, in ethanol),
31
 
dichloroanthracene (ΦF = 0.58, in ethanol)
30 
and 9,10-Diphenylanthracene (DPA) (ΦF = 
0.95 in ethanol),
32
 and gave the following values 0.27, 0.56, 0.91 that are in very good 
agreement with the literature values. 
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Chapter 6 
6 Future Outlook 
 
We have achieved the synthesis of a PNA monomer bearing the 4-(N,N-
dimethylamino)azobenzene unit as a nucleobase replacement and have 
successfully incorporated into an 8-mer PNA oligomer.  Furthermore, we have 
demonstrated the utility of the 4-(N,N-dimethylamino)azobenzene unit to act as a 
quencher in a PNA-molecular beacon (PNA-MB) design utilizing fluorescein as the 
luminophore. The 4-(N,N-dimethylamino)azobenzene showed high quenching ability 
upon hybridization of the PNA-MB to the complementary deoxynucleic acid.  Signalling 
of the hybridization event occurred by recovery of the fluorescence emission of 
fluorescein by over 100 fold.  
 
The presence of an azobenzene unit in PNA oligomer caused an increase in the stability 
of the triplex structure formed between 2PNA containing thymine residues with the 
complementary DNA. These results encourage us to investigate the quenching ability, 
photoresponse and stability effect of some azobenzene derivatives with large fused ring 
systems such as phenanthrenyl and anthracenyl phenylazo derivatives as shown in (Fig. 
6-1). These modifications may lead to increase the quenching range and stabilizing effect 
on the hybrid formed due to the good intercalation of the phenylazo derivatives into the 
helical structure. 
  
 
Figure ‎6-1: Stuctures of phenylazo derivatives. 
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We have also synthesized a modified uracil by introduction of phenylazo moiety at C5 to 
yield a uracil analogue that showed intrinsic quenching ability. A PNA monomer 
possessing the modified uracil was synthesized and it showed quenching ability to 
quench fluorescein emission in a short FRET-peptide design that was used as substrate 
for Cathepsin D enzyme. The advantage of this modification is that it provides the 
possibility to attach the modified azo-uracil at any position of the designed PNA 
oligomer and therefore may lead to increase the stability of the formed hybrid compared 
to the traditional azobenzene due to retaining its hydrogen bonding ability.  
 
In addition, we aimed to introduce the azo-based uracil into DNA and RNA chemistry by 
formation of the corresponding phosphoramidites. Formation of DNA and RNA 
molecular beacon containing the azo-modified uracil may show quenching ability. 
Incorporation of several azo-modifed uracil units into DNA may result in                         
a photoresponsive oligomer, that is, the ability to photoregulate duplex formation with                  
a complementary nucleic acid sequence through irradiation with light of a specific 
wavelength. 
 
 Incorporation of the modified azo-based uracil PNA monomer into PNA oligomer is 
underway to assess its ability to photoregulate the duplex structure that obtained with the 
complementary nucleic acid. We will investigate the effect of extending the ring size of 
phenylazo moiety on the quenching ability of the modified uracil as shown in (Fig.6-2). 
 
 
 
 
 
 
Figure ‎6-2: Structures of azo-based uracil derivatives. 
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Appendices 
Selected NMR and MS spectra 
1
H NMR (400 MHz, CDCl3) of II-1. 
 
 
1
H NMR (400 MHz, DMSO-d6) II-2. 
 
 II-1H.ESP
4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0
Chemical Shift (ppm)
II-2.ESP
9.5 9.0 8.5 8.0 7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0
Chemical Shift (ppm)
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1
H NMR (400 MHz, DMSO-d6)  of II-3. 
 
 
13
C NMR (100 MHz, CDCl3) of II-3. 
  
 
 
II-2.ESP
9.0 8.5 8.0 7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0
Chemical Shift (ppm)
II-3C.ESP
180 170 160 150 140 130 120 110 100 90 80 70 60 50 40
Chemical Shift (ppm)
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1
H NMR (400 MHz, CDCl3) of II-4. 
 
 
 
13
CNMR (100 MHz, CDCl3)  of II-4. 
 
  
 
II-4H.ESP
9.0 8.5 8.0 7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0
Chemical Shift (ppm)
II-4C.ESP
152 144 136 128 120 112 104 96 88 80 72 64 56 48 40 32 24
Chemical Shift (ppm)
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1
H NMR (400 MHz, CDCl3) of II-5. 
 
 
 
13
C NMR (100 MHz, CDCl3)  of II-5. 
 
 
II-5H.ESP
8.5 8.0 7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0
Chemical Shift (ppm)
II-5C.ESP
160 152 144 136 128 120 112 104 96 88 80 72 64 56 48 40
Chemical Shift (ppm)
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1
H NMR (400 MHz, DMSO-d6) of  III-1. 
 
 
13
CNMR (100 Mz, DMSO-d6) of III-1. 
 
 
 
1H.ESP
11 10 9 8 7 6 5 4 3 2
Chemical Shift (ppm)
 
1C.ESP
180 170 160 150 140 130 120 110 100 90 80 70 60 50 40 30
Chemical Shift (ppm)
 
143 
 
Ms of III-1. 
 
 
1
H NMR (400 MHz, DMSO-d6) of  III-2. 
 
 
2H.ESP
12 11 10 9 8 7 6 5 4 3 2 1 0
Chemical Shift (ppm)
 
144 
 
13
C NMR (100 MHz, DMSO-d6) of  of  III-2. 
 
 
 
Ms of III-2. 
 
 
2C.ESP
170 160 150 140 130 120 110 100 90 80 70 60 50 40 30 20
Chemical Shift (ppm)
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1
H NMR (400 MHz, DMSO-d6) of of  III-3. 
 
 
13
C NMR (100 MHz, DMSO-d6) of  of  III-3. 
 
 
3H.ESP
13 12 11 10 9 8 7 6 5 4 3 2
Chemical Shift (ppm)
 
3C.ESP
176 168 160 152 144 136 128 120 112 104 96 88 80 72 64 56 48 40
Chemical Shift (ppm)
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MS of III-3. 
 
 
1
H NMR (400 MHz, DMSO-d6) of  of  III-4. 
 
 
 
4H.ESP
12 11 10 9 8 7 6 5 4 3 2 1
Chemical Shift (ppm)
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13
C NMR (100 MHz, DMSO-d6) of  III-4. 
 
 
1
H NMR (400 MHz, DMSO-d6) of  III-5.
 
 
 
 
4C.ESP
168 160 152 144 136 128 120 112 104 96 88 80 72 64 56 48 40 32 24
Chemical Shift (ppm)
5H.ESP
11 10 9 8 7 6 5 4 3 2
Chemical Shift (ppm)
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1
H NMR (400 MHz, DMSO-d6) of  IV-2. 
 
 
1
H NMR (400 MHz, CH3OD) of of  IV-2. 
 
 
'.ESP
11 10 9 8 7 6 5 4 3 2
Chemical Shift (ppm)
H.ESP
9.0 8.5 8.0 7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0
Chemical Shift (ppm)
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13
C NMR (100 MHz, CH3OD) of  IV-3. 
 
 
1
H NMR (400 MHz, CDCl3) of  IV-3 
 
 
C.ESP
168 160 152 144 136 128 120 112 104 96 88 80 72 64 56 48 40 32
Chemical Shift (ppm)
H.ESP
8.5 8.0 7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0
Chemical Shift (ppm)
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13
C NMR (100 MHz, CDCl3)  IV-3 
 
 
1
H NMR (400 MHz, CDCl3)  of IV-4. 
 
 
C.ESP
160 152 144 136 128 120 112 104 96 88 80 72 64 56 48 40
Chemical Shift (ppm)
H.ESP
8.0 7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5
Chemical Shift (ppm)
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13
C NMR (100 MHz, CDCl3) of of IV-4. 
 
 
 
31
P NMR of of IV-4. 
 
 
 
C.ESP
160 152 144 136 128 120 112 104 96 88 80 72 64 56 48 40 32 24 16
Chemical Shift (ppm)
P.ESP
184 176 168 160 152 144 136 128 120 112 104 96 88 80 72 64 56 48
Chemical Shift (ppm)
152 
 
V-1.ESP
8.5 8.0 7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0
Chemical Shift (ppm)
1
H NMR (400 MHz, DMSO-d6) of V-1. 
 
 
 
 
 
 
 
 
 
1
H NMR (400 MHz, DMSO-d6) of V-2. 
 
 
 
V-2H.ESP
12 11 10 9 8 7 6 5 4 3 2
Chemical Shift (ppm)
153 
 
 
13
C NMR (100 MHz, DMSO-d6) of V-2. 
 
 
MS of V-2. 
 
 
 
 
V-2C.ESP
180 170 160 150 140 130 120 110 100 90 80 70 60 50 40 30
Chemical Shift (ppm)
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13
C NMR (100 MHz, DMSO-d6) of V-3. 
 
 
MS OF V-3. 
 
 
 
V-3C.ESP
170 160 150 140 130 120 110 100 90 80 70 60 50 40 30 20 10 0
Chemical Shift (ppm)
155 
 
 
1
H NMR (400 MHz, DMSO-d6) of V-4. 
 
 
13
C NMR (100 MHz, DMSO- d6) of V-4. 
 
 
V-4H.ESP
13 12 11 10 9 8 7 6 5 4 3 2
Chemical Shift (ppm)
V-4C.ESP
168 160 152 144 136 128 120 112 104 96 88 80 72 64 56 48 40 32
Chemical Shift (ppm)
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MS OF V-4. 
 
 
1
H NMR (400 MHz, DMSO- d6) of V-5. 
 
 
 
V-5H.ESP
10 9 8 7 6 5 4 3 2
Chemical Shift (ppm)
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13
C NMR (400 MHz, DMSO- d6) of V-5. 
 
 
MS of V-6. 
 
 
 
 
CARBON_01.ESP
180 170 160 150 140 130 120 110 100 90 80 70 60 50 40 30
Chemical Shift (ppm)
158 
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